Monocytic	O
cell	O
type-specific	O
transcriptional	O
induction	O
of	O
collagenase	B-protein
.	O

Interstitial	O
collagenase	B-protein
(	O
MMP-1	B-protein
)	O
,	O
a	O
metalloproteinase	B-protein
produced	O
by	O
resident	B-cell_type
and	I-cell_type
inflammatory	I-cell_type
cells	I-cell_type
during	O
connective	O
tissue	O
turnover	O
,	O
cleaves	O
type	B-protein
I	I-protein
collagen	I-protein
fibrils	I-protein
.	O

This	O
catalytic	O
event	O
is	O
rate	O
limiting	O
in	O
remodeling	O
of	O
tissues	O
rich	O
in	O
fibrillar	B-protein
collagen	I-protein
such	O
as	O
the	O
skin	O
and	O
lungs	O
.	O

The	O
regulation	O
of	O
collagenase	B-protein
expression	O
is	O
cell-type	O
specific	O
;	O
bacterial	O
LPS	O
and	O
zymosan	O
,	O
a	O
yeast	O
cell	O
wall	O
derivative	O
,	O
are	O
potent	O
inducers	O
of	O
collagenase	B-protein
expression	O
in	O
macrophages	B-cell_type
,	O
but	O
do	O
not	O
alter	O
fibroblast	B-cell_type
collagenase	B-protein
expression	O
.	O

Since	O
promoter	O
elements	O
controlling	O
collagenase	B-protein
transcription	O
in	O
monocytic	O
cells	O
have	O
not	O
been	O
previously	O
defined	O
,	O
we	O
sought	O
to	O
delineate	O
responsive	O
cis-acting	B-DNA
elements	I-DNA
of	O
the	O
collagenase	B-DNA
promoter	I-DNA
in	O
transiently	O
transfected	O
human	B-cell_line
(	I-cell_line
U937	I-cell_line
)	I-cell_line
and	I-cell_line
murine	I-cell_line
(	I-cell_line
J774	I-cell_line
)	I-cell_line
monocytic	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Deletion	O
constructs	O
containing	O
as	O
little	O
as	O
72	O
bp	O
of	O
5	B-DNA
'	I-DNA
-flanking	I-DNA
sequence	I-DNA
of	O
the	O
collagenase	B-DNA
promoter	I-DNA
were	O
sufficient	O
for	O
LPS-	O
or	O
zymosan-mediated	O
transcriptional	O
induction	O
,	O
whereas	O
phorbol	O
inducibility	O
exhibited	O
an	O
absolute	O
requirement	O
for	O
upstream	O
elements	O
including	O
the	O
polyoma	B-DNA
enhancer	I-DNA
A-binding	I-DNA
protein-3	I-DNA
site	I-DNA
(	O
-83	B-DNA
to	I-DNA
-91	I-DNA
)	O
and	O
TTCA	B-DNA
sequence	I-DNA
(	O
-102	B-DNA
to	I-DNA
-105	I-DNA
)	O
in	O
both	O
monocytic	B-cell_type
cells	I-cell_type
and	O
fibroblasts	B-cell_type
.	O

Mutagenesis	O
of	O
the	O
activator	B-DNA
protein-1	I-DNA
[	I-DNA
AP-1	I-DNA
]	I-DNA
site	I-DNA
at	O
-72	B-DNA
abolished	O
basal	B-DNA
promoter	I-DNA
activity	O
and	O
LPS/zymosan	O
inducibility	O
,	O
while	O
mutagenesis	O
of	O
an	O
NF-kappaB-like	B-DNA
site	I-DNA
at	O
-20	O
to	O
-10	O
had	O
no	O
effect	O
.	O

Nuclear	O
extracts	O
from	O
LPS	O
-and	O
zymosan-treated	B-cell_type
cells	I-cell_type
showed	O
strong	O
AP-1	B-protein
activity	O
by	O
gel-shift	O
analysis	O
,	O
and	O
supershift	O
analysis	O
showed	O
the	O
AP-1	B-protein
complexes	I-protein
contained	O
specific	O
members	O
of	O
both	O
the	O
jun	B-DNA
and	I-DNA
fos	I-DNA
gene	I-DNA
families	I-DNA
.	O

These	O
data	O
indicate	O
that	O
,	O
in	O
contrast	O
to	O
most	O
LPS	O
effects	O
,	O
AP-1	B-protein
,	O
but	O
not	O
nuclear	B-protein
factor-kappaB	I-protein
,	O
mediates	O
LPS	O
induction	O
of	O
collagenase	B-protein
transcription	O
in	O
macrophagelike	B-cell_type
cells	I-cell_type
.	O

Furthermore	O
,	O
as	O
compared	O
to	O
regulation	O
by	O
phorbol	O
ester	O
,	O
collagenase	B-protein
induction	O
in	O
monocytic	B-cell_type
cells	I-cell_type
by	O
cell	O
wall	O
derivatives	O
of	O
bacteria	O
or	O
yeast	O
is	O
largely	O
independent	O
of	O
upstream	B-DNA
promoter	I-DNA
sequences	I-DNA
.	O

Monocytic	NULL
Cell	NULL
Type-specific	NULL
Transcriptional	NULL
Induction	NULL
of	NULL
Collagenase	NULL
R.A.	NULL
Pierce	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
G.A.R	NULL
.	NULL

Doyle	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
Division	NULL
of	NULL
Dermatology	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
at	NULL
Jewish	NULL
Hospital	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
Abstract	NULL
Interstitial	NULL
collagenase	NULL
(	NULL
MMP-1	NULL
)	NULL
,	NULL
a	NULL
metalloproteinase	NULL
produced	NULL
by	NULL
resident	NULL
and	NULL
inflammatory	NULL
cells	NULL
during	NULL
connective	NULL
tissue	NULL
turnover	NULL
,	NULL
cleaves	NULL
type	NULL
I	NULL
collagen	NULL
fibrils	NULL
.	NULL

This	NULL
catalytic	NULL
event	NULL
is	NULL
rate	NULL
limiting	NULL
in	NULL
remodeling	NULL
of	NULL
tissues	NULL
rich	NULL
in	NULL
fibrillar	NULL
collagen	NULL
such	NULL
as	NULL
the	NULL
skin	NULL
and	NULL
lungs	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
collagenase	NULL
expression	NULL
is	NULL
cell-type	NULL
specific	NULL
;	NULL
bacterial	NULL
LPS	NULL
and	NULL
zymosan	NULL
,	NULL
a	NULL
yeast	NULL
cell	NULL
wall	NULL
derivative	NULL
,	NULL
are	NULL
potent	NULL
inducers	NULL
of	NULL
collagenase	NULL
expression	NULL
in	NULL
macrophages	NULL
,	NULL
but	NULL
do	NULL
not	NULL
alter	NULL
fibroblast	NULL
collagenase	NULL
expression	NULL
.	NULL

Since	NULL
promoter	NULL
elements	NULL
controlling	NULL
collagenase	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
previously	NULL
defined	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
delineate	NULL
responsive	NULL
cis-acting	NULL
elements	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
in	NULL
transiently	NULL
transfected	NULL
human	NULL
(	NULL
U937	NULL
)	NULL
and	NULL
murine	NULL
(	NULL
J774	NULL
)	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Deletion	NULL
constructs	NULL
containing	NULL
as	NULL
little	NULL
as	NULL
72	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
sequence	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
were	NULL
sufficient	NULL
for	NULL
LPS-	NULL
or	NULL
zymosan-mediated	NULL
transcriptional	NULL
induction	NULL
,	NULL
whereas	NULL
phorbol	NULL
inducibility	NULL
exhibited	NULL
an	NULL
absolute	NULL
requirement	NULL
for	NULL
upstream	NULL
elements	NULL
including	NULL
the	NULL
polyoma	NULL
enhancer	NULL
A-binding	NULL
protein-3	NULL
site	NULL
(	NULL
-83	NULL
to	NULL
-91	NULL
)	NULL
and	NULL
TTCA	NULL
sequence	NULL
(	NULL
-102	NULL
to	NULL
-105	NULL
)	NULL
in	NULL
both	NULL
monocytic	NULL
cells	NULL
and	NULL
fibroblasts	NULL
.	NULL

Mutagenesis	NULL
of	NULL
the	NULL
activator	NULL
protein-1	NULL
[	NULL
AP-1	NULL
]	NULL
site	NULL
at	NULL
-72	NULL
abolished	NULL
basal	NULL
promoter	NULL
activity	NULL
and	NULL
LPS/zymosan	NULL
inducibility	NULL
,	NULL
while	NULL
mutagenesis	NULL
of	NULL
an	NULL
NF-kB-like	NULL
site	NULL
at	NULL
-20	NULL
to	NULL
-10	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
LPS-	NULL
and	NULL
zymosan-treated	NULL
cells	NULL
showed	NULL
strong	NULL
AP-1	NULL
activity	NULL
by	NULL
gel-shift	NULL
analysis	NULL
,	NULL
and	NULL
supershift	NULL
analysis	NULL
showed	NULL
the	NULL
AP-1	NULL
complexes	NULL
contained	NULL
specific	NULL
members	NULL
of	NULL
both	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
gene	NULL
families	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
most	NULL
LPS	NULL
effects	NULL
,	NULL
AP-1	NULL
,	NULL
but	NULL
not	NULL
nuclear	NULL
factor-k	NULL
B	NULL
,	NULL
mediates	NULL
LPS	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
in	NULL
macrophagelike	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
regulation	NULL
by	NULL
phorbol	NULL
ester	NULL
,	NULL
collagenase	NULL
induction	NULL
in	NULL
monocytic	NULL
cells	NULL
by	NULL
cell	NULL
wall	NULL
derivatives	NULL
of	NULL
bacteria	NULL
or	NULL
yeast	NULL
is	NULL
largely	NULL
independent	NULL
of	NULL
upstream	NULL
promoter	NULL
sequences	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1996	NULL
.	NULL

97:1890-1899	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
collagenase	NULL
«	NULL
transcription	NULL
«	NULL
monocytic	NULL
«	NULL
LPS	NULL
»	NULL
AP-1	NULL
Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Richard	NULL
A	NULL
.	NULL

Pierce	NULL
,	NULL
Division	NULL
of	NULL
Dermatology	NULL
,	NULL
Jewish	NULL
Hospital	NULL
,	NULL
216	NULL
South	NULL
Kingshighway	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
.	NULL

Phone	NULL
:	NULL
314-454-8284	NULL
;	NULL
FAX	NULL
:	NULL
314-454-8293	NULL
;	NULL
E-mail	NULL
:	NULL
rpierce	NULL
@	NULL
imgate.wustl.edu	NULL
Received	NULL
for	NULL
publication	NULL
9	NULL
November	NULL
1995	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
16	NULL
January	NULL
1996	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/96/04/1890/10	NULL
$	NULL
2.00	NULL
Volume	NULL
97	NULL
,	NULL
Number	NULL
8	NULL
,	NULL
April	NULL
1996	NULL
,	NULL
1890-1899	NULL
1890	NULL
R.A.	NULL
Pierce	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
G.	NULL
A.	NULL
Doyle	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
Introduction	NULL
In	NULL
vertebrate	NULL
tissues	NULL
,	NULL
abundant	NULL
fibrillar	NULL
collagens	NULL
,	NULL
which	NULL
are	NULL
resistant	NULL
to	NULL
most	NULL
proteinases	NULL
,	NULL
provide	NULL
a	NULL
durable	NULL
architecture	NULL
.	NULL

Only	NULL
three	NULL
vertebrate	NULL
proteinases	NULL
efficiently	NULL
degrade	NULL
fibrillar	NULL
collagens	NULL
;	NULL
thus	NULL
,	NULL
this	NULL
step	NULL
is	NULL
often	NULL
rate	NULL
limiting	NULL
in	NULL
tissue	NULL
remod-eling	NULL
.	NULL

These	NULL
collagenases	NULL
,	NULL
which	NULL
are	NULL
interstitial	NULL
collagenase	NULL
(	NULL
MMP-1	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
neutrophil	NULL
collagenase	NULL
(	NULL
MMP-8	NULL
)	NULL
(	NULL
3	NULL
)	NULL
,	NULL
and	NULL
col-lagenase-3	NULL
(	NULL
MMP-13	NULL
)	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
are	NULL
members	NULL
of	NULL
the	NULL
matrix	NULL
metalloproteinase	NULL
(	NULL
MMP	NULL
)	NULL
family	NULL
of	NULL
enzymes	NULL
.	NULL

Collectively	NULL
,	NULL
MMPs	NULL
can	NULL
degrade	NULL
virtually	NULL
all	NULL
components	NULL
of	NULL
the	NULL
extracellular	NULL
matrix	NULL
(	NULL
6	NULL
)	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
MMP-1	NULL
is	NULL
the	NULL
predominant	NULL
collagenase	NULL
of	NULL
resident	NULL
cells	NULL
such	NULL
as	NULL
fibroblasts	NULL
and	NULL
keratinocytes	NULL
,	NULL
and	NULL
also	NULL
of	NULL
tissue	NULL
macrophages	NULL
.	NULL

MMP-13	NULL
expression	NULL
in	NULL
humans	NULL
is	NULL
apparently	NULL
much	NULL
more	NULL
restricted	NULL
,	NULL
being	NULL
observed	NULL
in	NULL
breast	NULL
carcinomas	NULL
(	NULL
5	NULL
)	NULL
and	NULL
articular	NULL
cartilage	NULL
(	NULL
Welgus	NULL
,	NULL
H.	NULL
,	NULL
unpublished	NULL
observa-tions	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
tissue	NULL
macrophages	NULL
.	NULL

However	NULL
,	NULL
in	NULL
rodents	NULL
MMP-13	NULL
is	NULL
the	NULL
only	NULL
collagenase	NULL
thus	NULL
far	NULL
identified	NULL
;	NULL
MMP-1	NULL
apparently	NULL
does	NULL
not	NULL
exist	NULL
as	NULL
a	NULL
functional	NULL
gene	NULL
in	NULL
rodents	NULL
.	NULL

In	NULL
humans	NULL
,	NULL
neutrophil	NULL
collagenase	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
PMNs	NULL
and	NULL
is	NULL
the	NULL
sole	NULL
collagenolytic	NULL
enzyme	NULL
of	NULL
those	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
interstitial	NULL
collagenase	NULL
(	NULL
MMP-1	NULL
)	NULL
is	NULL
cell-type	NULL
specific	NULL
.	NULL

Resident	NULL
cells	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
fibroblasts	NULL
,	NULL
keratinocytes	NULL
,	NULL
endothelial	NULL
cells	NULL
)	NULL
can	NULL
produce	NULL
interstitial	NULL
collagenase	NULL
and	NULL
other	NULL
metalloproteinases	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
factors	NULL
such	NULL
as	NULL
EGF	NULL
(	NULL
7	NULL
)	NULL
and	NULL
basic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
in	NULL
response	NULL
to	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
TNF-	NULL
(	NULL
9	NULL
)	NULL
and	NULL
IL-1	NULL
(	NULL
10	NULL
)	NULL
,	NULL
but	NULL
macrophages	NULL
are	NULL
not	NULL
responsive	NULL
to	NULL
these	NULL
factors	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mediators	NULL
such	NULL
as	NULL
LPS	NULL
(	NULL
11	NULL
)	NULL
and	NULL
zymosan	NULL
(	NULL
12	NULL
)	NULL
induce	NULL
collagenase	NULL
production	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
,	NULL
but	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
production	NULL
of	NULL
collagenase	NULL
or	NULL
other	NULL
metalloproteinases	NULL
by	NULL
resident	NULL
cells	NULL
of	NULL
epithelial	NULL
or	NULL
mesenchymal	NULL
origin	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
collagenase	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
likely	NULL
transcriptionally	NULL
mediated	NULL
,	NULL
as	NULL
the	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
when	NULL
differentiated	NULL
with	NULL
phorbol	NULL
ester	NULL
,	NULL
increases	NULL
collagenase	NULL
transcription	NULL
when	NULL
exposed	NULL
to	NULL
LPS	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
controlling	NULL
metalloproteinase	NULL
expression	NULL
in	NULL
resident	NULL
cells	NULL
such	NULL
as	NULL
fibroblasts	NULL
and	NULL
kerati-nocytes	NULL
have	NULL
been	NULL
exclusively	NULL
studied	NULL
.	NULL

The	NULL
promoters	NULL
of	NULL
the	NULL
interstitial	NULL
collagenase	NULL
and	NULL
stromelysin-1	NULL
genes	NULL
are	NULL
similar	NULL
in	NULL
overall	NULL
structure	NULL
(	NULL
14	NULL
)	NULL
,	NULL
and	NULL
these	NULL
genes	NULL
are	NULL
often	NULL
coordinately	NULL
regulated	NULL
.	NULL

Transcriptional	NULL
induction	NULL
of	NULL
the	NULL
collagenase	NULL
and	NULL
stromelysin	NULL
promoters	NULL
in	NULL
fibroblasts	NULL
is	NULL
dependent	NULL
not	NULL
only	NULL
on	NULL
the	NULL
prototypical	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
'	NULL
sites	NULL
found	NULL
near	NULL
the	NULL
transcription	NULL
start	NULL
sites	NULL
of	NULL
these	NULL
promoters	NULL
,	NULL
but	NULL
also	NULL
upon	NULL
upstream	NULL
sequences	NULL
including	NULL
a	NULL
polyoma	NULL
enhancer	NULL
A-binding	NULL
protein-3	NULL
(	NULL
PEA-3	NULL
)	NULL
site	NULL
and	NULL
TTCA	NULL
element	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
resident	NULL
cells	NULL
of	NULL
mesenchymal	NULL
or	NULL
epithelial	NULL
origin	NULL
,	NULL
upstream	NULL
sequences	NULL
are	NULL
critical	NULL
for	NULL
inducibility	NULL
of	NULL
collagenase	NULL
expression	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
NF-kB	NULL
,	NULL
nuclear	NULL
factor-kB	NULL
;	NULL
PEA-3	NULL
,	NULL
polyona	NULL
enhancer	NULL
A-binding	NULL
protein-3	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
such	NULL
resident	NULL
cells	NULL
,	NULL
the	NULL
gene	NULL
regulation	NULL
of	NULL
metalloproteinase	NULL
expression	NULL
in	NULL
mononuclear	NULL
phagocytes	NULL
has	NULL
not	NULL
been	NULL
studied	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
because	NULL
of	NULL
the	NULL
difficulty	NULL
in	NULL
transfecting	NULL
these	NULL
populations	NULL
.	NULL

Yet	NULL
collagenase	NULL
expression	NULL
by	NULL
macrophages	NULL
is	NULL
prominent	NULL
in	NULL
inflammatory	NULL
and	NULL
matrix-destructive	NULL
diseases	NULL
including	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
16,17	NULL
)	NULL
,	NULL
atherosclerosis	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
and	NULL
idiopathic	NULL
pneumonia	NULL
syndrome	NULL
(	NULL
Welgus	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Bacterial	NULL
LPS	NULL
activation	NULL
of	NULL
macrophages	NULL
causes	NULL
a	NULL
marked	NULL
induction	NULL
of	NULL
interstitial	NULL
collagenase	NULL
expression	NULL
(	NULL
11	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
induction	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
(	NULL
20	NULL
)	NULL
,	NULL
TNF-	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
phagocytosis	NULL
of	NULL
zymosan	NULL
,	NULL
a	NULL
yeast	NULL
cell	NULL
wall	NULL
derivative	NULL
,	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
diverse	NULL
macrophage	NULL
func-tions	NULL
,	NULL
including	NULL
the	NULL
production	NULL
of	NULL
interstitial	NULL
collagenase	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
many	NULL
inflammatory	NULL
genes	NULL
in	NULL
macrophages	NULL
such	NULL
as	NULL
TNF-a	NULL
(	NULL
23-25	NULL
)	NULL
,	NULL
IL-1	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
tissue	NULL
factor	NULL
(	NULL
27	NULL
)	NULL
by	NULL
LPS	NULL
is	NULL
mediated	NULL
,	NULL
in	NULL
large	NULL
part	NULL
,	NULL
by	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
pleiotropic	NULL
transcriptional	NULL
transactivator	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
collagenase	NULL
promoter	NULL
contains	NULL
a	NULL
sequence	NULL
at	NULL
-20	NULL
to	NULL
-10	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
consensus	NULL
NF-xB-binding	NULL
sequences	NULL
.	NULL

In	NULL
this	NULL
manuscript	NULL
,	NULL
we	NULL
have	NULL
delineated	NULL
promoter	NULL
sequences	NULL
necessary	NULL
for	NULL
monocytic	NULL
transcriptional	NULL
induction	NULL
of	NULL
collagenase	NULL
in	NULL
response	NULL
to	NULL
the	NULL
cell	NULL
type-specific	NULL
stimulating	NULL
agents	NULL
LPS	NULL
and	NULL
zymosan	NULL
by	NULL
employing	NULL
a	NULL
transient	NULL
transfection	NULL
strategy	NULL
with	NULL
promoter	NULL
chloramphenicol	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
constructs	NULL
derived	NULL
from	NULL
the	NULL
collagenase	NULL
gene	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
found	NULL
that	NULL
maximal	NULL
fold	NULL
induction	NULL
of	NULL
collagenase	NULL
promoter	NULL
activity	NULL
by	NULL
LPS	NULL
or	NULL
zymosan	NULL
was	NULL
conferred	NULL
by	NULL
constructs	NULL
containing	NULL
as	NULL
little	NULL
as	NULL
72	NULL
bp	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
abolished	NULL
both	NULL
basal	NULL
activity	NULL
and	NULL
induction	NULL
of	NULL
promoter	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
site	NULL
did	NULL
not	NULL
affect	NULL
either	NULL
basal	NULL
activity	NULL
or	NULL
induction	NULL
of	NULL
transcription	NULL
.	NULL

Binding	NULL
of	NULL
specific	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
gene	NULL
family	NULL
to	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
was	NULL
strongly	NULL
induced	NULL
by	NULL
LPS	NULL
treatment	NULL
,	NULL
implicating	NULL
AP-1	NULL
in	NULL
transactivation	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
origin	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
resident	NULL
cells	NULL
such	NULL
as	NULL
fibroblasts	NULL
,	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
is	NULL
mediated	NULL
almost	NULL
entirely	NULL
through	NULL
proximal	NULL
promoter	NULL
elements	NULL
involving	NULL
mainly	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

Methods	NULL
U937	NULL
Cell	NULL
culture	NULL
,	NULL
transfections	NULL
,	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Human	NULL
U937	NULL
cells	NULL
(	NULL
CLR	NULL
1593	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
serum-containing	NULL
RPMI	NULL
1640	NULL
medium	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
for	NULL
all	NULL
treatments	NULL
and	NULL
at	NULL
1.8	NULL
x	NULL
10	NULL
%	NULL
/cm	NULL
on	NULL
tissue	NULL
culture	NULL
plastic	NULL
(	NULL
Costar	NULL
Corp.	NULL
,	NULL
Cam-bridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

To	NULL
differentiate	NULL
U937	NULL
cells	NULL
for	NULL
adherence	NULL
and	NULL
to	NULL
prime	NULL
for	NULL
LPS	NULL
stimulations	NULL
,	NULL
PMA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
in	NULL
DMSO	NULL
was	NULL
added	NULL
at	NULL
50	NULL
ng/m	NULL
!	NULL

to	NULL
the	NULL
medium	NULL
alone	NULL
or	NULL
simultaneously	NULL
with	NULL
LPS	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
.	NULL

Control	NULL
cultures	NULL
received	NULL
vehicle	NULL
alone	NULL
.	NULL

For	NULL
each	NULL
promoter-CAT	NULL
construct	NULL
,	NULL
1	NULL
X	NULL
10	NULL
``	NULL
U937	NULL
cells	NULL
in	NULL
1.5	NULL
ml	NULL
of	NULL
medium	NULL
were	NULL
transiently	NULL
transfected	NULL
in	NULL
suspension	NULL
by	NULL
exposure	NULL
to	NULL
75	NULL
g	NULL
DEAE-Dextran	NULL
(	NULL
Profection	NULL
kit	NULL
;	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
supercoiled	NULL
column-purified	NULL
DNA	NULL
(	NULL
QIAGEN	NULL
,	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
.	NULL

After	NULL
pelleting	NULL
by	NULL
gentle	NULL
centrifugation	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
60	NULL
ml	NULL
of	NULL
medium	NULL
and	NULL
divided	NULL
into	NULL
three	NULL
100-cm	NULL
>	NULL
dishes	NULL
to	NULL
recover	NULL
overnight	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
washed	NULL
and	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
,	NULL
medium	NULL
containing	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
,	NULL
or	NULL
medium	NULL
containing	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
plus	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
24	NULL
h	NULL
with	NULL
a	NULL
cell	NULL
scraper	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
lysates	NULL
,	NULL
normalized	NULL
for	NULL
total	NULL
protein	NULL
(	NULL
Bradford	NULL
protein	NULL
assay	NULL
;	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
above	NULL
.	NULL

J774	NULL
Cell	NULL
culture	NULL
,	NULL
transfections	NULL
,	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

Murine	NULL
J774	NULL
cells	NULL
(	NULL
TIB	NULL
67	NULL
;	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-denatured	NULL
FBS	NULL
,	NULL
nonessential	NULL
amino	NULL
acids	NULL
,	NULL
L-glutamine	NULL
,	NULL
and	NULL
penicillin-streptomycin	NULL
.	NULL

These	NULL
spontaneously	NULL
adherent	NULL
,	NULL
macrophagelike	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
6-well	NULL
cluster	NULL
dishes	NULL
containing	NULL
5	NULL
X	NULL
10°	NULL
cells/well	NULL
.	NULL

Liposome-mediated	NULL
cotransfection	NULL
of	NULL
these	NULL
cells	NULL
used	NULL
LipofectAMINE	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
at	NULL
10	NULL
mg/ml	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
supercoiled	NULL
promoter-CAT	NULL
construct	NULL
with	NULL
1	NULL
g	NULL
of	NULL
plasmid	NULL
cytomegalovirus	NULL
(	NULL
pCMV	NULL
)	NULL
-B-ga-lactosidase	NULL
as	NULL
a	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
or	NULL
medium	NULL
containing	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
or	NULL
zymosan	NULL
at	NULL
1	NULL
mg/ml	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
preparation	NULL
of	NULL
lysates	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
assayed	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
30	NULL
)	NULL
and	NULL
subsequently	NULL
for	NULL
CAT	NULL
activity	NULL
using	NULL
acetyl	NULL
CoA	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
and	NULL
[	NULL
!	NULL

*CJchloramphenicol	NULL
(	NULL
DuPont-NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
TLC	NULL
and	NULL
autoradiography	NULL
.	NULL

Human	NULL
skin	NULL
fibroblast	NULL
culture	NULL
.	NULL

Primary	NULL
cultures	NULL
of	NULL
human	NULL
skin	NULL
fibroblasts	NULL
were	NULL
obtained	NULL
by	NULL
explanting	NULL
from	NULL
newborn	NULL
foreskins	NULL
.	NULL

Cultures	NULL
were	NULL
maintained	NULL
in	NULL
supplemented	NULL
DMEM	NULL
identical	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
used	NULL
for	NULL
J774	NULL
cells	NULL
.	NULL

Passage	NULL
3-8	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
P-100	NULL
dishes	NULL
at	NULL
1.5	NULL
%	NULL
10°	NULL
cells	NULL
per	NULL
dish	NULL
and	NULL
cotransfected	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
with	NULL
20	NULL
g	NULL
of	NULL
each	NULL
collagenase-CAT	NULL
construct	NULL
and	NULL
5	NULL
g	NULL
of	NULL
pCMV-B-galactosidase	NULL
as	NULL
a	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

After	NULL
6	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
shocked	NULL
with	NULL
15	NULL
%	NULL
glycerol	NULL
for	NULL
2	NULL
min	NULL
,	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
control	NULL
medium	NULL
,	NULL
medium	NULL
containing	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
,	NULL
or	NULL
medium	NULL
containing	NULL
LPS	NULL
at	NULL
10	NULL
ug/ml	NULL
for	NULL
24	NULL
h	NULL
before	NULL
harvest	NULL
by	NULL
scraping	NULL
.	NULL

Lysates	NULL
were	NULL
prepared	NULL
,	NULL
assayed	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
and	NULL
subsequently	NULL
for	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
above	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
hybridization	NULL
.	NULL

Northern	NULL
analyses	NULL
were	NULL
done	NULL
to	NULL
determine	NULL
the	NULL
degree	NULL
of	NULL
induction	NULL
of	NULL
collagenase	NULL
gene	NULL
expression	NULL
with	NULL
various	NULL
treatments	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
10	NULL
``	NULL
treated	NULL
or	NULL
control	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Northern	NULL
hybridizations	NULL
were	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
29	NULL
)	NULL
.	NULL

DNA	NULL
probes	NULL
were	NULL
radiolabeled	NULL
by	NULL
random	NULL
priming	NULL
with	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
dCTP	NULL
.	NULL

Human	NULL
procollagenase	NULL
mRNA	NULL
from	NULL
U937	NULL
cells	NULL
was	NULL
hybridized	NULL
with	NULL
a	NULL
full-length	NULL
human	NULL
procollagenase	NULL
cDNA	NULL
;	NULL
mouse	NULL
collagenase	NULL
mRNA	NULL
from	NULL
J774	NULL
cells	NULL
was	NULL
detected	NULL
with	NULL
pUMR	NULL
Case	NULL
,	NULL
a	NULL
2.2-kb	NULL
rat	NULL
collagenase	NULL
cDNA	NULL
clone	NULL
(	NULL
4	NULL
)	NULL
.	NULL

For	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
mRNA	NULL
,	NULL
pRGAPDH13	NULL
,	NULL
a	NULL
1.3-kb	NULL
rat	NULL
cDNA	NULL
,	NULL
was	NULL
used	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

After	NULL
stringent	NULL
washing	NULL
,	NULL
membranes	NULL
were	NULL
exposed	NULL
to	NULL
AR	NULL
x-ray	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-70°C	NULL
for	NULL
4	NULL
to	NULL
24	NULL
h	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Construction	NULL
of	NULL
reporter	NULL
constructs	NULL
.	NULL

The	NULL
construct	NULL
pCLCAT	NULL
,	NULL
containing	NULL
sequences	NULL
from	NULL
-2278	NULL
to	NULL
+36	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
promoter	NULL
,	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
Stephen	NULL
Frisch	NULL
(	NULL
La	NULL
Jolla	NULL
Cancer	NULL
Research	NULL
Foundation	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
PstI	NULL
site	NULL
was	NULL
mutated	NULL
to	NULL
an	NULL
Xhol	NULL
site	NULL
,	NULL
then	NULL
the	NULL
HindIII/Xhol	NULL
fragment	NULL
containing	NULL
the	NULL
human	NULL
collagenase	NULL
promoter	NULL
sequences	NULL
of	NULL
pCLCAT	NULL
was	NULL
subcloned	NULL
into	NULL
HindIII/Xhol	NULL
digested	NULL
pBLCAT2	NULL
(	NULL
34	NULL
)	NULL
,	NULL
giving	NULL
rise	NULL
to	NULL
pCL-2278CAT	NULL
.	NULL

A	NULL
series	NULL
of	NULL
deletion	NULL
constructs	NULL
were	NULL
synthesized	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
linearized	NULL
pCL-2278CAT	NULL
,	NULL
in	NULL
each	NULL
case	NULL
using	NULL
a	NULL
unique	NULL
5	NULL
'	NULL
primer	NULL
with	NULL
an	NULL
engineered	NULL
HindIII	NULL
site	NULL
and	NULL
a	NULL
common	NULL
3	NULL
'	NULL
primer	NULL
within	NULL
the	NULL
CAT	NULL
gene	NULL
.	NULL

The	NULL
resultant	NULL
PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Xhol	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
HindIII/Xhol	NULL
digested	NULL
pBLCAT2	NULL
backbone	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primers	NULL
used	NULL
in	NULL
the	NULL
PCR	NULL
amplification	NULL
,	NULL
named	NULL
for	NULL
the	NULL
most	NULL
5	NULL
'	NULL
nucleotide	NULL
with	NULL
identity	NULL
to	NULL
collagenase	NULL
promoter	NULL
sequences	NULL
,	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
-511	NULL
:	NULL
5CAGGAAGCTTAACAAAGGCAGAAAGG3	NULL
'	NULL
,	NULL
-179	NULL
;	NULL
5'TTTGAAGCTTATCATGACATTGCAAF	NULL
'	NULL
,	NULL
-95	NULL
:	NULL
STTCAAAGCTTATCAAGAGGATGTTA3	NULL
'	NULL
,	NULL
-72	NULL
:	NULL
STATAAAGCTTGAGTCAGACACCTCT3	NULL
'	NULL
,	NULL
-55	NULL
:	NULL
5	NULL
``	NULL
CCTCAAGCTTTCTGGAAGGGCAAGGA3	NULL
'	NULL
,	NULL
-34	NULL
:	NULL
5°GGGCAAGCTTTCTATATATACAGAG3	NULL
'	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
3	NULL
'	NULL
primer	NULL
,	NULL
complementary	NULL
to	NULL
sequences	NULL
within	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
contained	NULL
in	NULL
pCL-	NULL
Cell	NULL
Type-specific	NULL
Collagenase	NULL
Transcription	NULL
1891	NULL
2278CAT	NULL
,	NULL
was	NULL
5	NULL
``	NULL
TTCATTGCATACGGAATTCCGGATG3	NULL
'	NULL
.	NULL

A	NULL
mutant	NULL
construct	NULL
,	NULL
pCL-2278CATmAP-1	NULL
,	NULL
with	NULL
the	NULL
AP-1	NULL
site	NULL
replaced	NULL
by	NULL
an	NULL
Smal	NULL
restriction	NULL
site	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
overlapping	NULL
PCR	NULL
mutagenesis	NULL
as	NULL
described	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
overlapping	NULL
primers	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
(	NULL
forward	NULL
primer	NULL
)	NULL
:	NULL
SGCACCCGGGAGACACCT	NULL
CTGGCTTTCT3	NULL
'	NULL
,	NULL
(	NULL
reverse	NULL
primer	NULL
)	NULL
:	NULL
S'TCTCCCGGGTGCTTITTAT	NULL
AAC	NULL
ATATCCTCT3	NULL
'	NULL
.	NULL

The	NULL
external	NULL
primers	NULL
were	NULL
:	NULL
(	NULL
forward	NULL
primer	NULL
)	NULL
:	NULL
S'AAGCCATGGTCGTATCGC3	NULL
'	NULL
,	NULL
(	NULL
reverse	NULL
primer	NULL
)	NULL
5°CCAATTCC	NULL
CTCGAGCCCGTAAGTGATG3	NULL
'	NULL
.	NULL

The	NULL
resultant	NULL
mutated	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
Xhol	NULL
.	NULL

The	NULL
digested	NULL
fragment	NULL
was	NULL
then	NULL
ligated	NULL
with	NULL
the	NULL
HindIII/KpnI	NULL
fragment	NULL
of	NULL
the	NULL
pCL-2278CAT	NULL
vector	NULL
and	NULL
HindIII/Xhol	NULL
digested	NULL
pBLCAT2	NULL
.	NULL

Constructs	NULL
=-511mAP-1	NULL
,	NULL
-179mAP-1	NULL
,	NULL
and	NULL
-95mAP-1	NULL
were	NULL
synthesized	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
pCL-2278CATmAP-1	NULL
using	NULL
the	NULL
specific	NULL
forward	NULL
primers	NULL
described	NULL
above	NULL
and	NULL
the	NULL
common	NULL
reverse	NULL
primer	NULL
complementary	NULL
to	NULL
sequences	NULL
within	NULL
the	NULL
CAT	NULL
gene	NULL
,	NULL
followed	NULL
by	NULL
restriction	NULL
digestion	NULL
with	NULL
HindIII	NULL
and	NULL
Xhol	NULL
and	NULL
subcloning	NULL
into	NULL
HindIII/Xhol	NULL
digested	NULL
pBLCAT2	NULL
.	NULL

Constructs	NULL
-179mNFkB	NULL
and	NULL
-95mNFkB	NULL
were	NULL
constructed	NULL
by	NULL
overlapping	NULL
PCR	NULL
mutagenesis	NULL
using	NULL
pCL-2278CAT	NULL
as	NULL
a	NULL
template	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
overlapping	NULL
PCR	NULL
primers	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
(	NULL
forward	NULL
primer	NULL
)	NULL
:	NULL
SGAGAACTACCA	NULL
AGCTGGGATATTGGAGC3	NULL
'	NULL
,	NULL
(	NULL
reverse	NULL
primer	NULL
)	NULL
:	NULL
S'TTGGTA-GTTCACTCTGTATATATAGAGT3	NULL
'	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
all	NULL
constructs	NULL
were	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
of	NULL
plasmid	NULL
DNA	NULL
(	NULL
Seque-nase	NULL
;	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
containing	NULL
PMA	NULL
(	NULL
50	NULL
ng/	NULL
ml	NULL
)	NULL
or	NULL
PMA	NULL
+	NULL
LPS	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
as	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
also	NULL
isolated	NULL
from	NULL
2	NULL
x	NULL
10°	NULL
J774	NULL
cells	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
or	NULL
medium	NULL
containing	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
or	NULL
zymosan	NULL
at	NULL
1	NULL
mg/ml	NULL
for	NULL
24	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
aliquoted	NULL
and	NULL
frozen	NULL
over	NULL
liquid	NULL
N	NULL
,	NULL
until	NULL
use	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
regions	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
,	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
,	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
P	NULL
]	NULL
-y-ATP	NULL
(	NULL
ICN	NULL
,	NULL
Biomedicals	NULL
,	NULL
Inc.	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Biochemicals	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
5	NULL
mg	NULL
of	NULL
nuclear	NULL
extract	NULL
protein	NULL
,	NULL
and	NULL
electrophoresed	NULL
through	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
g	NULL
poly	NULL
(	NULL
dL	NULL
:	NULL
dC/dI	NULL
:	NULL
dC	NULL
)	NULL
and	NULL
5-	NULL
to	NULL
50-fold	NULL
excess	NULL
of	NULL
specific	NULL
or	NULL
mutant	NULL
unlabeled	NULL
competitors	NULL
for	NULL
15	NULL
min	NULL
at	NULL
25°C	NULL
,	NULL
then	NULL
40,000	NULL
to	NULL
100,000	NULL
cpm	NULL
of	NULL
probe	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
25°C	NULL
.	NULL

For	NULL
supershift	NULL
assays	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
chilled	NULL
on	NULL
ice	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
antibody	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
continued	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Antibodies	NULL
were	NULL
rabbit	NULL
polyclonals	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
raised	NULL
against	NULL
specific	NULL
fos	NULL
or	NULL
jun	NULL
peptide	NULL
sequences	NULL
as	NULL
follows	NULL
:	NULL
the	NULL
pan-jun-specific	NULL
antibody	NULL
(	NULL
c-jun/AP-1	NULL
[	NULL
D	NULL
]	NULL
)	NULL
recognizes	NULL
the	NULL
COOH	NULL
terminus	NULL
of	NULL
mouse	NULL
c-Jun	NULL
p39	NULL
;	NULL
the	NULL
c-Jun	NULL
antibody	NULL
(	NULL
c-jun/AP-1	NULL
[	NULL
N	NULL
]	NULL
)	NULL
recognizes	NULL
amino	NULL
acids	NULL
95-105	NULL
of	NULL
mouse	NULL
c-Jun	NULL
p39	NULL
;	NULL
the	NULL
Jun	NULL
B	NULL
antibody	NULL
(	NULL
jun	NULL
B	NULL
[	NULL
N-17	NULL
]	NULL
)	NULL
recognizes	NULL
amino	NULL
acids	NULL
45-61	NULL
of	NULL
mouse	NULL
Jun	NULL
B	NULL
p39	NULL
;	NULL
the	NULL
pan-Fos-specific	NULL
antibody	NULL
(	NULL
c-fos-	NULL
[	NULL
K-25	NULL
]	NULL
)	NULL
was	NULL
raised	NULL
against	NULL
amino	NULL
acids	NULL
128-152	NULL
of	NULL
human	NULL
c-fos	NULL
p62	NULL
;	NULL
the	NULL
c-fos-specific	NULL
antibody	NULL
(	NULL
c-fos	NULL
[	NULL
4	NULL
]	NULL
)	NULL
was	NULL
raised	NULL
to	NULL
amino	NULL
acids	NULL
3-16	NULL
of	NULL
human	NULL
c-Fos	NULL
p62	NULL
;	NULL
and	NULL
the	NULL
Fos	NULL
B-specific	NULL
antibody	NULL
was	NULL
raised	NULL
to	NULL
amino	NULL
acids	NULL
102-117	NULL
of	NULL
the	NULL
mouse	NULL
fos	NULL
B	NULL
gene	NULL
product	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
centrifuged	NULL
at	NULL
4,000	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
then	NULL
electrophoresed	NULL
through	NULL
5	NULL
%	NULL
acrylamide	NULL
gels	NULL
at	NULL
250	NULL
V	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
for	NULL
12-30	NULL
h.	NULL
Results	NULL
LPS	NULL
treatment	NULL
upregulates	NULL
collagenase	NULL
mRNA	NULL
expression	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
induction	NULL
of	NULL
interstitial	NULL
collagenases	NULL
in	NULL
monocytic	NULL
cells	NULL
by	NULL
LPS	NULL
treatment	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
PMA-differentiated	NULL
,	NULL
LPS-treated	NULL
,	NULL
human	NULL
U937	NULL
cells	NULL
.	NULL

Interstitial	NULL
collagenase	NULL
mRNA	NULL
was	NULL
undetectable	NULL
in	NULL
control	NULL
cells	NULL
,	NULL
in	NULL
1892	NULL
-	NULL
R.A.	NULL
Pierce	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
G.A	NULL
.	NULL

Doyle	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
Figure	NULL
1	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
collagenase	NULL
mRNA	NULL
in	NULL
U937	NULL
and	NULL
J774	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Human	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
C	NULL
)	NULL
,	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
with	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
plus	NULL
10	NULL
pg/ml	NULL
of	NULL
LPS	NULL
(	NULL
P+L	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
then	NULL
harvested	NULL
for	NULL
RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
collagenase	NULL
mRNA	NULL
levels	NULL
.	NULL

Collagenase	NULL
mRNA	NULL
is	NULL
induced	NULL
by	NULL
PMA	NULL
and	NULL
further	NULL
induced	NULL
by	NULL
LPS	NULL
treatment	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Murine	NULL
J774	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
C	NULL
)	NULL
or	NULL
with	NULL
10	NULL
ug/ml	NULL
of	NULL
LPS	NULL
(	NULL
L	NULL
)	NULL
for	NULL
24	NULL
h	NULL
,	NULL
then	NULL
harvested	NULL
for	NULL
RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
collagenase	NULL
mRNA	NULL
levels	NULL
.	NULL

Collagenase	NULL
mRNA	NULL
is	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

ap	NULL
--	NULL
Human	NULL
Case	NULL
--	NULL
GAPDH	NULL
.	NULL

--	NULL
Murine	NULL
Case	NULL
@	NULL
a=	NULL
-	NULL
GAPDH	NULL
duced	NULL
by	NULL
PMA	NULL
differentiation	NULL
,	NULL
and	NULL
markedly	NULL
potentiated	NULL
by	NULL
LPS	NULL
treatment	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
spontaneously	NULL
adherent	NULL
mouse	NULL
J774	NULL
cells	NULL
,	NULL
collagenase	NULL
mRNA	NULL
was	NULL
undetectable	NULL
in	NULL
control	NULL
cultures	NULL
,	NULL
but	NULL
was	NULL
markedly	NULL
induced	NULL
in	NULL
LPS-treated	NULL
cultures	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
were	NULL
uniformly	NULL
seen	NULL
in	NULL
multiple	NULL
experiments	NULL
.	NULL

LPS-responsive	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
MMP-1	NULL
promoter	NULL
differ	NULL
from	NULL
PMA-responsive	NULL
elements	NULL
and	NULL
reside	NULL
near	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Previous	NULL
studies	NULL
indicate	NULL
that	NULL
LPS	NULL
stimulation	NULL
of	NULL
collagenase	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
was	NULL
transcriptionally	NULL
mediated	NULL
(	NULL
13	NULL
)	NULL
.	NULL

To	NULL
delineate	NULL
LPS-responsive	NULL
elements	NULL
in	NULL
the	NULL
collagenase	NULL
(	NULL
human	NULL
MMP-1	NULL
)	NULL
promoter	NULL
,	NULL
a	NULL
series	NULL
of	NULL
collagenase	NULL
promoter-CAT	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
4	NULL
)	NULL
were	NULL
used	NULL
in	NULL
transient	NULL
transfections	NULL
of	NULL
PMA-differentiated	NULL
human	NULL
U937	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
induction	NULL
of	NULL
promoter	NULL
activity	NULL
of	NULL
LPS	NULL
treatment	NULL
was	NULL
evident	NULL
in	NULL
all	NULL
constructs	NULL
containing	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
including	NULL
pCL-72CAT	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
quantified	NULL
in	NULL
Table	NULL
I	NULL
,	NULL
the	NULL
fold	NULL
induction	NULL
by	NULL
LPS	NULL
was	NULL
very	NULL
similar	NULL
in	NULL
pCL-72CAT	NULL
to	NULL
all	NULL
other	NULL
constructs	NULL
containing	NULL
additional	NULL
upstream	NULL
sequences	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
fold	NULL
induction	NULL
of	NULL
transcription	NULL
with	NULL
PMA	NULL
treatment	NULL
diminished	NULL
markedly	NULL
with	NULL
deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-179	NULL
and	NULL
-95	NULL
(	NULL
lacking	NULL
TTCA	NULL
)	NULL
and	NULL
no	NULL
PMA-mediated	NULL
induction	NULL
was	NULL
observed	NULL
with	NULL
pCL-72CAT	NULL
(	NULL
Lacking	NULL
TTCA	NULL
and	NULL
PEA-3	NULL
,	NULL
but	NULL
containing	NULL
AP-1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
in	NULL
monocytes	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
fibroblasts	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
,	NULL
PMA	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
is	NULL
dependent	NULL
upon	NULL
Table	NULL
I	NULL
.	NULL

Induction	NULL
of	NULL
Collagenase	NULL
Promoter	NULL
Activity	NULL
by	NULL
PMA	NULL
and	NULL
LPS	NULL
Promoter	NULL
U937	NULL
cells	NULL
.	NULL

U937	NULL
cells	NULL
,	NULL
J774	NULL
cells	NULL
.	NULL

construct	NULL
LPS/PMA	NULL
PM	NULL
A/control	NULL
LPS/control	NULL
-2278	NULL
4.7	NULL
6.4	NULL
4.1	NULL
-551	NULL
3.9	NULL
4.8	NULL
4.6	NULL
-179	NULL
4.3	NULL
3.3	NULL
4.8	NULL
-95	NULL
2.8	NULL
1.3	NULL
8.5	NULL
-72	NULL
3.8	NULL
0.7	NULL
4.8	NULL
-55	NULL
1.0	NULL
0.8	NULL
1.4	NULL
-34	NULL
1.3	NULL
0.8	NULL
1.1	NULL
Data	NULL
are	NULL
derived	NULL
from	NULL
scintillation	NULL
counting	NULL
of	NULL
the	NULL
thin	NULL
layer	NULL
chromato-graphs	NULL
which	NULL
were	NULL
exposed	NULL
for	NULL
autoradiography	NULL
and	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C.	NULL
Control	NULL
values	NULL
are	NULL
set	NULL
to	NULL
1.0	NULL
and	NULL
numbers	NULL
presented	NULL
indicate	NULL
fold	NULL
stimulation	NULL
relative	NULL
to	NULL
control	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
LPS/PMA	NULL
for	NULL
U937	NULL
cells	NULL
,	NULL
PMA	NULL
values	NULL
are	NULL
set	NULL
to	NULL
1.0	NULL
and	NULL
numbers	NULL
presented	NULL
indicated	NULL
LPS	NULL
stimulation	NULL
relative	NULL
to	NULL
PMA	NULL
.	NULL

A	NULL
pOL-2278CAT	NULL
1	NULL
/	NULL
arc	NULL
150	NULL
poust1cat	NULL
ise	NULL
Api	NULL
[	NULL
ran	NULL
|-	NULL
+s6	NULL
pCL-179CAT-	NULL
pCL-72CAT	NULL
NF-kB	NULL
+36	NULL
pCL-55CAT	NULL
NF-kB	NULL
+36	NULL
Figure	NULL
2	NULL
.	NULL

Deletion	NULL
analysis	NULL
indicates	NULL
LPS-responsive	NULL
elements	NULL
reside	NULL
near	NULL
the	NULL
collagenase	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
deletion	NULL
series	NULL
,	NULL
containing	NULL
from	NULL
2278	NULL
to	NULL
34	NULL
nucleotides	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
(	NULL
MMP-1	NULL
)	NULL
promoter	NULL
and	NULL
extending	NULL
to	NULL
+36	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
was	NULL
con-structed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
ATCATGACATTGCAACAC	NULL
CZIXAGTGATTCCMATAATCTGCIITAGGAGTCAIC	NULL
CATTTCTAA	NULL
179	NULL
-170	NULL
-160	NULL
+150	NULL
~140	NULL
TTCA	NULL
PEA-3	NULL
AP-1	NULL
TGATTGCCTAQTCTATTCATQGCTAATCAAIGAGGATGTTA	NULL
‘	NULL
II	NULL
‘	NULL
TAAAGCATGIILGTCAGACAC	NULL
+120	NULL
110	NULL
~100	NULL
90	NULL
80	NULL
TATA	NULL
NF-	NULL
KB-like	NULL
ICTCTGGCTTTQTGGAAGGGCIAAGGACTCTATATATACAGAQGGAGCTTCC'ZFAGCTGGGAT	NULL
-60	NULL
~50	NULL
A0	NULL
30	NULL
-20	NULL
B	NULL
Construct	NULL
+2278	NULL
transiently	NULL
transfected	NULL
with	NULL
collagenase	NULL
promoter-CAT	NULL
constructs	NULL
,	NULL
divided	NULL
into	NULL
treatment	NULL
groups	NULL
,	NULL
then	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
control	NULL
medium	NULL
,	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
or	NULL
50	NULL
ng/ml	NULL
of	NULL
PMA	NULL
plus	NULL
10	NULL
ug/ml	NULL
LPS	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
lysates	NULL
prepared	NULL
for	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

Constructs	NULL
containing	NULL
from	NULL
2278	NULL
to	NULL
179	NULL
nucleotides	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
sequence	NULL
were	NULL
induced	NULL
by	NULL
PMA	NULL
,	NULL
130	NULL
10	NULL
10	NULL
J00	NULL
e0e000	NULL
o	NULL
000	NULL
while	NULL
induction	NULL
by	NULL
LPS	NULL
occurred	NULL
with	NULL
the	NULL
-95	NULL
and	NULL
-72	NULL
constructs	NULL
as	NULL
well	NULL
.	NULL

(	NULL
C	NULL
)	NULL
J774	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
collagenase	NULL
promoter-CAT	NULL
con	NULL
pma	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
LPS	NULL
+	NULL
+	NULL
+	NULL
+	NULL
C	NULL
Construct	NULL
2278	NULL
11	NULL
179	NULL
-95	NULL
-72	NULL
-55	NULL
34	NULL
f	NULL
«	NULL
>	NULL
*	NULL
e	NULL
*	NULL
a	NULL
__	NULL
&	NULL
C	NULL
*	NULL
Lrs	NULL
-o	NULL
0	NULL
-	NULL
#	NULL
o-	NULL
#	NULL
0	NULL
+	NULL
#	NULL
-	NULL
$	NULL
o	NULL
-	NULL
#	NULL
-	NULL
+	NULL
D	NULL
Construct	NULL
Construct	NULL
511	NULL
«	NULL
95	NULL
2278	NULL
179	NULL
structs	NULL
and	NULL
CMV-BGal	NULL
,	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
10	NULL
g/ml	NULL
LPS	NULL
,	NULL
then	NULL
harvested	NULL
for	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Note	NULL
that	NULL
LPS-mediated	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
was	NULL
evident	NULL
in	NULL
constructs	NULL
containing	NULL
from	NULL
2278	NULL
to	NULL
72	NULL
nucleotides	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
sequence	NULL
.	NULL

(	NULL
DD	NULL
)	NULL
Human	NULL
dermal	NULL
fibroblasts	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
collagenase	NULL
promoter-CAT	NULL
constructs	NULL
and	NULL
CMV-BGal	NULL
,	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
ng/ml	NULL
PMA	NULL
,	NULL
then	NULL
harvested	NULL
for	NULL
+	NULL
+	NULL
+	NULL
++	NULL
95	NULL
12	NULL
-55	NULL
(	NULL
TRE	NULL
)	NULL
,	NULL
TK	NULL
®	NULL
a	NULL
a	NULL
*	NULL
#	NULL
8	NULL
%	NULL
»	NULL
«	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Transcriptional	NULL
induction	NULL
was	NULL
evident	NULL
in	NULL
the	NULL
-511	NULL
construct	NULL
,	NULL
but	NULL
absent	NULL
in	NULL
both	NULL
the	NULL
-95	NULL
and	NULL
-72	NULL
PMA	NULL
ime	NULL
-	NULL
+	NULL
-	NULL
+	NULL
+	NULL
LPS	NULL
-	NULL
+	NULL
constructs	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Human	NULL
dermal	NULL
fi-	NULL
-	NULL
%	NULL
wop	NULL
:	NULL
(	NULL
-	NULL
}	NULL
$	NULL
)	NULL
=	NULL
«	NULL
-	NULL
<	NULL
h	NULL
broblasts	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
either	NULL
collagenase	NULL
promoter-CAT-deletion	NULL
constructs	NULL
or	NULL
a	NULL
heterologous	NULL
construct	NULL
containing	NULL
three	NULL
tandem	NULL
AP-1	NULL
sites	NULL
and	NULL
the	NULL
HSV	NULL
TK	NULL
promoter	NULL
,	NULL
and	NULL
CMV-BGal	NULL
,	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
,	NULL
then	NULL
harvested	NULL
for	NULL
analysis	NULL
for	NULL
CAT	NULL
activity	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

No	NULL
induction	NULL
was	NULL
observed	NULL
.	NULL

upstream	NULL
sequences	NULL
,	NULL
such	NULL
as	NULL
TTCA	NULL
and	NULL
PEA-3	NULL
.	NULL

However	NULL
,	NULL
LPS-induced	NULL
collagenase	NULL
transcription	NULL
exhibited	NULL
no	NULL
such	NULL
de-pendence	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
J774	NULL
cells	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
or	NULL
LPS	NULL
at	NULL
10	NULL
ug/ml	NULL
for	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
,	NULL
LPS	NULL
induction	NULL
persisted	NULL
in	NULL
all	NULL
constructs	NULL
containing	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
fold	NULL
induction	NULL
of	NULL
the	NULL
-72	NULL
construct	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
was	NULL
nearly	NULL
identical	NULL
in	NULL
magnitude	NULL
to	NULL
that	NULL
exhibited	NULL
by	NULL
the	NULL
-511	NULL
,	NULL
-179	NULL
,	NULL
and	NULL
-95	NULL
constructs	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Both	NULL
basal	NULL
promoter	NULL
activity	NULL
and	NULL
LPS	NULL
induction	NULL
were	NULL
absent	NULL
in	NULL
the	NULL
-55	NULL
and	NULL
-34	NULL
constructs	NULL
that	NULL
do	NULL
not	NULL
contain	NULL
the	NULL
AP-1	NULL
sequence	NULL
.	NULL

To	NULL
compare	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
with	NULL
interstitial	NULL
cells	NULL
,	NULL
human	NULL
dermal	NULL
fibroblasts	NULL
were	NULL
transfected	NULL
with	NULL
collagenase	NULL
promoter	NULL
deletion	NULL
constructs	NULL
and	NULL
treated	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
LPS	NULL
for	NULL
24	NULL
h.	NULL
In	NULL
these	NULL
cells	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
38	NULL
)	NULL
,	NULL
sequences	NULL
5	NULL
'	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
were	NULL
required	NULL
for	NULL
PMA	NULL
responsiveness	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
a	NULL
-95	NULL
construct	NULL
containing	NULL
AP-1	NULL
and	NULL
PEA-3	NULL
elements	NULL
,	NULL
but	NULL
lacking	NULL
TTCA	NULL
,	NULL
exhibited	NULL
no	NULL
phorbol	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

As	NULL
antici-pated	NULL
,	NULL
human	NULL
dermal	NULL
fibroblasts	NULL
were	NULL
not	NULL
competent	NULL
to	NULL
upregulate	NULL
collagenase	NULL
promoter	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
E	NULL
)	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
using	NULL
constructs	NULL
containing	NULL
from	NULL
2278	NULL
to	NULL
34	NULL
bp	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
,	NULL
LPS	NULL
induction	NULL
was	NULL
never	NULL
evident	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
LPS	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
and	NULL
Cell	NULL
Type-specific	NULL
Collagenase	NULL
Transcription	NULL
1893	NULL
A	NULL
B	NULL
Construct	NULL
«	NULL
2278	NULL
2278	NULL
Construct	NULL
«	NULL
2278	NULL
TK	NULL
cat	NULL
(	NULL
TREp	NULL
:	NULL
TKCat	NULL
72	NULL
e	NULL
e	NULL
«	NULL
&	NULL
=	NULL
@	NULL
@	NULL
e	NULL
«	NULL
=	NULL
tin	NULL
«	NULL
tte	NULL
o	NULL
o	NULL
o	NULL
0	NULL
|	NULL
|	NULL
o	NULL
o	NULL
e	NULL
o	NULL
ee0c0e	NULL
o	NULL
@	NULL
cce	NULL
eoce	NULL
a	NULL
s	NULL
C	NULL
C	NULL
P	NULL
0	NULL
C	NULL
U	NULL
e	NULL
-	NULL
%	NULL
e	NULL
_	NULL
e	NULL
e	NULL
e	NULL
e	NULL
a	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
e	NULL
%	NULL
Time	NULL
40	NULL
B	NULL
12	NULL
24	NULL
40	NULL
8	NULL
12	NULL
24	NULL
LPS	NULL
o	NULL
2	NULL
10	NULL
0	NULL
2	NULL
10	NULL
0	NULL
a	NULL
r	NULL
10	NULL
oo	NULL
o	NULL
2	NULL
a0	NULL
0	NULL
PMA	NULL
£0	NULL
0s	NULL
%	NULL
-o-	NULL
+	NULL
so-	NULL
<	NULL
%	NULL
-o	NULL
>	NULL
>	NULL
+	NULL
Treatment	NULL
Control	NULL
LPS	NULL
Figure	NULL
3	NULL
.	NULL

Time	NULL
course	NULL
and	NULL
dose	NULL
response	NULL
of	NULL
LPS	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
J774	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
-2278CLCAT	NULL
,	NULL
treated	NULL
with	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
for	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
or	NULL
24	NULL
h	NULL
,	NULL
then	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Induction	NULL
of	NULL
transcription	NULL
was	NULL
evident	NULL
by	NULL
12	NULL
h	NULL
,	NULL
and	NULL
continued	NULL
at	NULL
24	NULL
h.	NULL
(	NULL
B	NULL
)	NULL
Dose	NULL
response	NULL
of	NULL
LPS	NULL
induction	NULL
.	NULL

J774	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
collagenase	NULL
promoter-CAT	NULL
constructs	NULL
or	NULL
heterologous	NULL
promoter-CAT	NULL
constructs	NULL
,	NULL
treated	NULL
with	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
or	NULL
LPS	NULL
at	NULL
2	NULL
or	NULL
10	NULL
pg/ml	NULL
for	NULL
24	NULL
h.	NULL
Cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

PMA-mediated	NULL
transcriptional	NULL
induction	NULL
was	NULL
evident	NULL
in	NULL
-2278CLCAT	NULL
and	NULL
a	NULL
heterologous	NULL
construct	NULL
containing	NULL
three	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
minimal	NULL
thymidine-kinase	NULL
promoter	NULL
or	NULL
the	NULL
native	NULL
collagenase	NULL
-72CLCAT	NULL
construct	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LPS-mediated	NULL
transcriptional	NULL
induction	NULL
was	NULL
complete	NULL
and	NULL
dose	NULL
dependent	NULL
in	NULL
the	NULL
native	NULL
collagenase	NULL
-72CLCAT	NULL
construct	NULL
.	NULL

differs	NULL
from	NULL
PMA	NULL
induction	NULL
of	NULL
collagenase	NULL
in	NULL
requirements	NULL
for	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
LPS	NULL
induction	NULL
of	NULL
collagenase	NULL
promoter	NULL
activity	NULL
.	NULL

We	NULL
were	NULL
interested	NULL
in	NULL
determining	NULL
the	NULL
time	NULL
course	NULL
of	NULL
induction	NULL
of	NULL
collagenase	NULL
promoter	NULL
activity	NULL
by	NULL
LPS	NULL
treatment	NULL
of	NULL
monocytic	NULL
cells	NULL
and	NULL
chose	NULL
to	NULL
perform	NULL
these	NULL
studies	NULL
in	NULL
the	NULL
murine	NULL
J774	NULL
cells	NULL
,	NULL
which	NULL
respond	NULL
directly	NULL
to	NULL
LPS	NULL
without	NULL
requiring	NULL
PMA	NULL
differentiation	NULL
.	NULL

J774	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
,	NULL
then	NULL
treated	NULL
with	NULL
LPS	NULL
for	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
or	NULL
24	NULL
h.	NULL
Collagenase	NULL
promoter	NULL
activity	NULL
was	NULL
slightly	NULL
induced	NULL
by	NULL
LPS	NULL
treatment	NULL
at	NULL
8	NULL
h	NULL
over	NULL
control	NULL
levels	NULL
,	NULL
was	NULL
fully	NULL
induced	NULL
by	NULL
12	NULL
h	NULL
,	NULL
and	NULL
continued	NULL
at	NULL
high	NULL
levels	NULL
through	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
A	NULL
pCL-227BmAP-1CAT	NULL
/	NULL
/	NULL
meegy	NULL
tag	NULL
_	NULL
:	NULL
pCL-179mNF-	NULL
«	NULL
BCAT	NULL
[	NULL
Trca	NULL
]	NULL
pEA-s	NULL
]	NULL
Ap	NULL
|	NULL
TATA	NULL
|	NULL
Nggel	NULL
--	NULL
+36	NULL
pCL-95mNF-xBCAT-	NULL
[	NULL
PEA-s	NULL
]	NULL
APA	NULL
[	NULL
TATA	NULL
|	NULL
Y	NULL
&	NULL
B	NULL
+36	NULL
pou-9smap-1cat	NULL
-	NULL
Pers	NULL
[	NULL
K	NULL
-	NULL
+26	NULL
Wild-type	NULL
AP-1	NULL
sequence	NULL
(	NULL
-72	NULL
to	NULL
-65	NULL
)	NULL
TGAGTCAG	NULL
Mutated	NULL
AP-1	NULL
sequence	NULL
(	NULL
-72	NULL
to	NULL
-65	NULL
)	NULL
cocecceac	NULL
Figure	NULL
4	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
LPS-mediated	NULL
transcriptional	NULL
induction	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
collagenase	NULL
AP-1	NULL
site	NULL
and	NULL
Consensus	NULL
NF-KB	NULL
sequence	NULL
cecceactrrcec	NULL
a	NULL
putative	NULL
NF-kB-like	NULL
site	NULL
were	NULL
mu-	NULL
,	NULL
¢	NULL
NF-kB	NULL
tated	NULL
in	NULL
the	NULL
context	NULL
of	NULL
deletion	NULL
con-Tissue-factor	NULL
NF-KB	NULL
sequence	NULL
CccecactTTTccr	NULL
structs	NULL
.	NULL

(	NULL
B	NULL
)	NULL
U937	NULL
cells	NULL
were	NULL
transiently	NULL
Collagenase	NULL
NF-xB-like	NULL
sequence	NULL
(	NULL
-20	NULL
to	NULL
-10	NULL
)	NULL
-	NULL
AGGGAGCTTCCT	NULL
transfected	NULL
,	NULL
treated	NULL
with	NULL
PMA	NULL
at	NULL
50	NULL
Mutated	NULL
NF-KB-like	NULL
sequence	NULL
(	NULL
-20	NULL
to	NULL
-10	NULL
)	NULL
AGAGCAACTACCT	NULL
ng/ml	NULL
or	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
plus	NULL
LPS	NULL
at	NULL
10	NULL
g/ml	NULL
for	NULL
24	NULL
h	NULL
,	NULL
then	NULL
harvested	NULL
and	NULL
B	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activ-Construct	NULL
_	NULL
2278	NULL
2278	NULL
mAP1	NULL
179	NULL
179mapP-1	NULL
-95	NULL
-95mAP-1	NULL
-34	NULL
ity	NULL
.	NULL

LPS	NULL
1ndqc1p111ty	NULL
was	NULL
evident	NULL
in	NULL
constructs	NULL
containing	NULL
2278	NULL
,	NULL
179	NULL
,	NULL
or	NULL
95	NULL
nucle-ing	NULL
*	NULL
eo	NULL
*	NULL
o	NULL
®	NULL
otides	NULL
of	NULL
promoter	NULL
sequences	NULL
,	NULL
but	NULL
©	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
eliminated	NULL
e	NULL
@	NULL
00	NULL
O00	NULL
000	NULL
@	NULL
00	NULL
se0e06	NULL
ee0	NULL
e00	NULL
both	NULL
basal	NULL
activity	NULL
ar'ld	NULL
inducibility	NULL
.	NULL

(	NULL
C	NULL
)	NULL
ok.	NULL
0+	NULL
$	NULL
0	NULL
a	NULL
0	NULL
%	NULL
406	NULL
b	NULL
e	NULL
e	NULL
i	NULL
%	NULL
%	NULL
5	NULL
on	NULL
%	NULL
J774	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
,	NULL
PMA	NULL
+	NULL
%	NULL
£	NULL
``	NULL
%	NULL
+o+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
0+	NULL
3	NULL
<	NULL
>	NULL
treated	NULL
with	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
for	NULL
24	NULL
h	NULL
,	NULL
LFS	NULL
*	NULL
*	NULL
M	NULL
*	NULL
*	NULL
*	NULL
*	NULL
then	NULL
harvested	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Two	NULL
separate	NULL
C	NULL
experiments	NULL
,	NULL
one	NULL
testing	NULL
mAP-1	NULL
con-Construct	NULL
2278	NULL
-	NULL
-2278mAP-A	NULL
|	NULL
479	NULL
_	NULL
179mAPA1	NULL
|	NULL
95	NULL
_	NULL
A5mAP1	NULL
179	NULL
~179mNF~B	NULL
structs	NULL
and	NULL
another	NULL
,	NULL
the	NULL
mNF-	NULL
«	NULL
B	NULL
construct	NULL
,	NULL
are	NULL
presented	NULL
.	NULL

Note	NULL
that	NULL
muta-©	NULL
%	NULL
tion	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-2278	NULL
,	NULL
-179	NULL
,	NULL
and	NULL
-95	NULL
constructs	NULL
abolished	NULL
basal	NULL
activity	NULL
and	NULL
LPS	NULL
induc-se	NULL
00	NULL
00	NULL
ee	NULL
o	NULL
0	NULL
®	NULL
0	NULL
ee	NULL
ee	NULL
ibility	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
site	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
LPS	NULL
induc-LPS	NULL
-	NULL
&	NULL
sot	NULL
nook	NULL
ol	NULL
c	NULL
#	NULL
o-	NULL
#	NULL
00	NULL
o-	NULL
:	NULL
#	NULL
-	NULL
©	NULL
=	NULL
+	NULL
ibility	NULL
.	NULL

1894	NULL
_	NULL
R.A.	NULL
Pierce	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
G.A	NULL
.	NULL

Doyle	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
increase	NULL
at	NULL
8	NULL
h	NULL
was	NULL
quite	NULL
evident	NULL
;	NULL
however	NULL
,	NULL
a	NULL
high	NULL
level	NULL
of	NULL
induction	NULL
was	NULL
always	NULL
observed	NULL
at	NULL
12	NULL
h.	NULL
LPS	NULL
induction	NULL
of	NULL
collagenase	NULL
promoter	NULL
activity	NULL
is	NULL
dose	NULL
re-sponsive	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
LPS-mediated	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
was	NULL
dose	NULL
dependent	NULL
,	NULL
transiently	NULL
transfected	NULL
J774	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
2	NULL
to	NULL
10	NULL
ug/ml	NULL
of	NULL
LPS	NULL
or	NULL
with	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
for	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Constructs	NULL
containing	NULL
2278	NULL
or	NULL
just	NULL
72	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
-flanking	NULL
sequence	NULL
were	NULL
equally	NULL
LPS	NULL
responsive	NULL
and	NULL
a	NULL
dose-dependent	NULL
increase	NULL
in	NULL
transcriptional	NULL
activity	NULL
was	NULL
observed	NULL
.	NULL

While	NULL
transcriptional	NULL
activity	NULL
from	NULL
the	NULL
-2278	NULL
construct	NULL
was	NULL
highly	NULL
responsive	NULL
to	NULL
PMA	NULL
,	NULL
the	NULL
-72	NULL
construct	NULL
was	NULL
completely	NULL
unresponsive	NULL
to	NULL
PMA	NULL
treatment	NULL
,	NULL
similar	NULL
to	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
.	NULL

A	NULL
control	NULL
plasmid	NULL
containing	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
CAT	NULL
gene	NULL
(	NULL
34	NULL
)	NULL
exhibited	NULL
no	NULL
transcriptional	NULL
activity	NULL
,	NULL
while	NULL
a	NULL
derived	NULL
construct	NULL
that	NULL
contains	NULL
three	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
Ap-1	NULL
site	NULL
inserted	NULL
5	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
exhibited	NULL
basal	NULL
activity	NULL
,	NULL
PMA	NULL
responsiveness	NULL
,	NULL
and	NULL
dose-dependent	NULL
induction	NULL
with	NULL
LPS	NULL
treatment	NULL
of	NULL
J774	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
further	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
single	NULL
collagenase	NULL
AP-1	NULL
site	NULL
linked	NULL
to	NULL
minimal	NULL
downstream	NULL
sequences	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
LPS-mediated	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
,	NULL
but	NULL
not	NULL
for	NULL
PMA-induced	NULL
transcription	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-	NULL
«	NULL
kB-like	NULL
site	NULL
,	NULL
is	NULL
necessary	NULL
for	NULL
LPS-mediated	NULL
transcriptional	NULL
induction	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
an	NULL
intact	NULL
AP-1	NULL
site	NULL
was	NULL
necessary	NULL
for	NULL
collagenase	NULL
transcription	NULL
in	NULL
the	NULL
context	NULL
of	NULL
larger	NULL
collagenase	NULL
promoter	NULL
fragments	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
AP-1	NULL
site	NULL
was	NULL
performed	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

In	NULL
U937	NULL
cells	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
ablated	NULL
transcriptional	NULL
activation	NULL
by	NULL
LPS	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-2278	NULL
,	NULL
-179	NULL
,	NULL
and	NULL
-95	NULL
collagenase	NULL
promoter-CAT	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
constructs	NULL
-2278mAP-1	NULL
,	NULL
-179mAP-1	NULL
,	NULL
and	NULL
-I95mAP-1	NULL
all	NULL
lacked	NULL
basal	NULL
activity	NULL
and	NULL
LPS	NULL
inducibility	NULL
in	NULL
transfected	NULL
J774	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
)	NULL
.	NULL

The	NULL
human	NULL
collagenase	NULL
promoter	NULL
contains	NULL
a	NULL
site	NULL
similar	NULL
to	NULL
consensus	NULL
sequences	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
NFkB	NULL
between	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
A	NULL
and	NULL
4	NULL
A	NULL
)	NULL
.	NULL

Because	NULL
NF-KB	NULL
is	NULL
a	NULL
common	NULL
transactivator	NULL
of	NULL
LPS-responsive	NULL
genes	NULL
associated	NULL
with	NULL
inflammation	NULL
(	NULL
28	NULL
)	NULL
,	NULL
we	NULL
mutated	NULL
the	NULL
collagenase	NULL
NF-	NULL
«	NULL
kB-like	NULL
site	NULL
to	NULL
test	NULL
whether	NULL
this	NULL
site	NULL
is	NULL
important	NULL
in	NULL
the	NULL
LPS-mediated	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
this	NULL
NF-kB-like	NULL
site	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
LPS	NULL
inducibility	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
B	NULL
«	NULL
2278	NULL
72	NULL
©	NULL
©	NULL
C	NULL
ZYM	NULL
--	NULL
Murine	NULL
Case	NULL
<	NULL
a	NULL
e	NULL
o	NULL
©	NULL
e	NULL
tap	NULL
@	NULL
@	NULL
|	NULL
-	NULL
capou	NULL
P	NULL
4	NULL
Co	NULL
Z	NULL
Co	NULL
Z	NULL
Figure	NULL
5	NULL
.	NULL

Zymosan	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
J774	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
control	NULL
medium	NULL
(	NULL
C	NULL
)	NULL
or	NULL
zymosan	NULL
(	NULL
ZYM	NULL
)	NULL
at	NULL
1	NULL
mg/ml	NULL
for	NULL
24	NULL
h	NULL
,	NULL
then	NULL
harvested	NULL
for	NULL
RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
analysis	NULL
of	NULL
murine	NULL
collagenase	NULL
mRNA	NULL
.	NULL

Note	NULL
that	NULL
zymosan	NULL
treatment	NULL
induced	NULL
collagenase	NULL
mRNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
J774	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CL-2278CAT	NULL
or	NULL
CL-72	NULL
CAT	NULL
,	NULL
treated	NULL
with	NULL
zymosan	NULL
at	NULL
1	NULL
mg/ml	NULL
for	NULL
24	NULL
h	NULL
,	NULL
and	NULL
then	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

Transcriptional	NULL
activity	NULL
was	NULL
potently	NULL
induced	NULL
by	NULL
zymosan	NULL
treatment	NULL
and	NULL
equivalently	NULL
in	NULL
the	NULL
-2278	NULL
,	NULL
and	NULL
-72	NULL
constructs	NULL
.	NULL

the	NULL
-179	NULL
promoter-CAT	NULL
construct	NULL
in	NULL
J774	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
experi-ment	NULL
,	NULL
which	NULL
was	NULL
performed	NULL
separately	NULL
from	NULL
the	NULL
experiment	NULL
testing	NULL
the	NULL
AP-1	NULL
mutants	NULL
,	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
due	NULL
to	NULL
a	NULL
lower	NULL
level	NULL
of	NULL
transfection	NULL
efficiency	NULL
.	NULL

However	NULL
,	NULL
LPS	NULL
inducibility	NULL
over	NULL
the	NULL
zero	NULL
background	NULL
was	NULL
evident	NULL
with	NULL
or	NULL
without	NULL
mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB-like	NULL
site	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
argue	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
but	NULL
not	NULL
the	NULL
NF-kB-like	NULL
site	NULL
,	NULL
is	NULL
necessary	NULL
for	NULL
LPS-mediated	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Zymosan	NULL
induction	NULL
of	NULL
collagenase	NULL
in	NULL
J774	NULL
cells	NULL
.	NULL

Our	NULL
experiments	NULL
indicated	NULL
that	NULL
LPS	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
was	NULL
mediated	NULL
primarily	NULL
through	NULL
the	NULL
AP-1	NULL
site	NULL
and	NULL
was	NULL
much	NULL
less	NULL
dependent	NULL
on	NULL
upstream	NULL
sequences	NULL
than	NULL
the	NULL
induction	NULL
of	NULL
collagenase	NULL
in	NULL
fibroblasts	NULL
or	NULL
monocytic	NULL
cells	NULL
by	NULL
PMA	NULL
.	NULL

We	NULL
were	NULL
therefore	NULL
interested	NULL
in	NULL
determining	NULL
whether	NULL
similar	NULL
regulatory	NULL
mechanisms	NULL
would	NULL
be	NULL
characteristic	NULL
of	NULL
zymosan	NULL
induction	NULL
of	NULL
collagenase	NULL
,	NULL
as	NULL
this	NULL
is	NULL
another	NULL
agent	NULL
that	NULL
,	NULL
like	NULL
LPS	NULL
,	NULL
activates	NULL
human	NULL
macrophage	NULL
collagenase	NULL
expression	NULL
,	NULL
but	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
collagenase	NULL
expression	NULL
in	NULL
other	NULL
cells	NULL
such	NULL
as	NULL
fibroblasts	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
spontaneously	NULL
adherent	NULL
J774	NULL
cells	NULL
respond	NULL
to	NULL
zymosan	NULL
by	NULL
upregulation	NULL
of	NULL
collagenase	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
PMA	NULL
-differentiated	NULL
U937	NULL
cells	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
zymosan	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
response	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
to	NULL
zymosan	NULL
in	NULL
J774	NULL
cells	NULL
.	NULL

Transiently	NULL
transfected	NULL
,	NULL
zymosan-treated	NULL
J774	NULL
cells	NULL
exhibited	NULL
marked	NULL
and	NULL
near-equivalent	NULL
induction	NULL
of	NULL
collagenase	NULL
promoter	NULL
activity	NULL
with	NULL
deletion	NULL
constructs	NULL
containing	NULL
2278	NULL
and	NULL
72	NULL
bp	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
deletion	NULL
constructs	NULL
containing	NULL
from	NULL
511	NULL
to	NULL
95	NULL
bp	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

LPS	NULL
and	NULL
zymosan	NULL
treatment	NULL
results	NULL
in	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
.	NULL

Because	NULL
our	NULL
transient	NULL
transfection	NULL
analysis	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
implicated	NULL
the	NULL
AP-1	NULL
element	NULL
in	NULL
both	NULL
LPS-	NULL
and	NULL
zymosan-mediated	NULL
induction	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
analyzing	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
complexes	NULL
in	NULL
U937	NULL
and	NULL
J774	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
PMA	NULL
or	NULL
PMA	NULL
plus	NULL
LPS	NULL
and	NULL
from	NULL
J774	NULL
cells	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
LPS	NULL
or	NULL
zymosan	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
quality	NULL
of	NULL
all	NULL
extracts	NULL
was	NULL
assessed	NULL
by	NULL
mobility-shift	NULL
assays	NULL
using	NULL
the	NULL
constitutive	NULL
nuclear	NULL
protein	NULL
Oct	NULL
1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
incubated	NULL
with	NULL
P-radiolabeled	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
collagenase	NULL
promoter	NULL
wild-type	NULL
AP-1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
untreated	NULL
U937	NULL
cells	NULL
exhibited	NULL
little	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
oligonucleotide	NULL
,	NULL
while	NULL
extracts	NULL
prepared	NULL
from	NULL
LPS-treated	NULL
,	NULL
PMA-differentiated	NULL
U937	NULL
cells	NULL
exhibited	NULL
greater	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
than	NULL
extracts	NULL
derived	NULL
from	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
fivefold	NULL
excess	NULL
unlabeled	NULL
AP-1	NULL
oligonucleotide	NULL
diminished	NULL
binding	NULL
and	NULL
a	NULL
50-fold	NULL
excess	NULL
abolished	NULL
bind-ing	NULL
,	NULL
while	NULL
mutant	NULL
competitor	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
binding	NULL
activity	NULL
.	NULL

Thus	NULL
,	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
is	NULL
potentiated	NULL
by	NULL
LPS	NULL
treatment	NULL
of	NULL
PMA-differentiated	NULL
U937	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
extracts	NULL
from	NULL
control	NULL
J774	NULL
cells	NULL
exhibited	NULL
some	NULL
binding	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
which	NULL
was	NULL
markedly	NULL
increased	NULL
in	NULL
extracts	NULL
from	NULL
LPS	NULL
treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
C	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
competed	NULL
by	NULL
a	NULL
fivefold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competitor	NULL
,	NULL
indicating	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
specificity	NULL
of	NULL
binding	NULL
.	NULL

Further	NULL
increases	NULL
in	NULL
unlabeled	NULL
competitor	NULL
abolished	NULL
specific	NULL
binding	NULL
completely	NULL
,	NULL
while	NULL
a	NULL
mutated	NULL
competitor	NULL
was	NULL
ineffective	NULL
in	NULL
competing	NULL
for	NULL
binding	NULL
even	NULL
at	NULL
a	NULL
50-fold	NULL
excess	NULL
concentration	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
from	NULL
zymosan-treated	NULL
J774	NULL
cells	NULL
,	NULL
a	NULL
marked	NULL
,	NULL
specific	NULL
in	NULL
Cell	NULL
Type-specific	NULL
Collagenase	NULL
Transcription	NULL
1895	NULL
A	NULL
l	NULL
5	NULL
'CATCAAAGCATCAGTCAGACACCT3®	NULL
Collagenase	NULL
AP-1	NULL
probe	NULL
'3TPPCGTACTCAGTCTETGGAcTAc	NULL
'	NULL
s	NULL
L	NULL
5'GATCAAAGCA	NULL
GAGACACCT3	NULL
:	NULL
Collagenase	NULL
mAP-1	NULL
probe	NULL
TCTGTGGACTAG	NULL
'	NULL
5	NULL
_	NULL
5	NULL
-	NULL
AcTTeaceccactrrcccacec	NULL
:	NULL
'	NULL
Consensus	NULL
NF-B	NULL
probe	NULL
'	NULL
3	NULL
TCAACTCCCCTGAAAGGGTCce	NULL
's	NULL
5	NULL
'	NULL
TATACAGACGGACCTTCCTAcCTEG	NULL
:	NULL
®	NULL
Collagenase	NULL
NF-KB-like	NULL
probe	NULL
'	NULL
2ATATGTCTCCCTCGAAGGATCGAC	NULL
's	NULL
C	NULL
Extract	NULL
-	NULL
Control	NULL
LPS	NULL
Competitor	NULL
|	NULL
-	NULL
sx	NULL
|	NULL
10	NULL
%	NULL
]	NULL
50	NULL
%	NULL
)	NULL
5X	NULL
|	NULL
10	NULL
%	NULL
]	NULL
SOX	NULL
Mutcompetitor|	NULL
-	NULL
50X	NULL
5	NULL
|50X	NULL
B	NULL
|_	NULL
Extract	NULL
__|	NULL
-	NULL
Emmi	NULL
PMA	NULL
PMA	NULL
+LPS	NULL
|_	NULL
Competitor	NULL
|	NULL
-	NULL
__|	NULL
sx	NULL
sx	NULL
|	NULL
10x	NULL
]	NULL
50	NULL
%	NULL
sx	NULL
|	NULL
10	NULL
%	NULL
]	NULL
sox	NULL
[	NULL
Mutcumpetrlur	NULL
]	NULL
-	NULL
J	NULL
50X	NULL
50X	NULL
w	NULL
I	NULL
J6	NULL
18	NULL
tt	NULL
b	NULL
E	NULL
Figure	NULL
6	NULL
.	NULL

AP-1	NULL
and	NULL
--	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
induced	NULL
by	NULL
Extract	NULL
Control	NULL
pma	NULL
LPS	NULL
treatment	NULL
.	NULL

(	NULL
A4	NULL
)	NULL
D	NULL
__	NULL
+	NULL
+	NULL
Oligonucleotides	NULL
used	NULL
Extract	NULL
-	NULL
Control	NULL
Zymosan	NULL
1	NULL
Eﬁﬂﬁfﬁgf	NULL
x	NULL
+	NULL
+	NULL
in	NULL
gel-Shift	NULL
assays	NULL
in-Competitor	NULL
|	NULL
-	NULL
sx	NULL
|1ox|sox|	NULL
__|	NULL
5x	NULL
|	NULL
rox	NULL
]	NULL
sox	NULL
clude	NULL
the	NULL
human	NULL
colla-mutcompetitor|	NULL
-	NULL
E	NULL
_	NULL
t*	NULL
u	NULL
t	NULL
genase	NULL
MMP-1	NULL
AP-1	NULL
site	NULL
,	NULL
the	NULL
human	NULL
colla-	NULL
f	NULL
H	NULL
«	NULL
g-	NULL
-	NULL
genase	NULL
NF-	NULL
«	NULL
B-like	NULL
site	NULL
,	NULL
and	NULL
a	NULL
consensus	NULL
H	NULL
-	NULL
NF-kB	NULL
sequence	NULL
.	NULL

(	NULL
B	NULL
)	NULL
®	NULL
wt	NULL
d	NULL
'	NULL
il	NULL
``	NULL
Gel-shift	NULL
assay	NULL
using	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
and	NULL
5	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
either	NULL
control	NULL
medium	NULL
,	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
,	NULL
or	NULL
MPA	NULL
at	NULL
50	NULL
ng/ml	NULL
plus	NULL
i	NULL
i	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
.	NULL

Note	NULL
.	NULL
'	NULL

.	NULL

.	NULL
'	NULL

.	NULL

G	NULL
i	NULL
that	NULL
specific	NULL
binding	NULL
activity	NULL
is	NULL
low	NULL
in	NULL
the	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
,	NULL
is	NULL
induced	NULL
in	NULL
extracts	NULL
from	NULL
PMA-differentiated	NULL
cells	NULL
,	NULL
and	NULL
is	NULL
augmented	NULL
further	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS-treated	NULL
cells	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Gel-shift	NULL
assay	NULL
using	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
and	NULL
5	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
J774	NULL
cells	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
control	NULL
medium	NULL
or	NULL
LPS	NULL
at	NULL
10	NULL
g/ml	NULL
.	NULL

Note	NULL
that	NULL
binding	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
the	NULL
unstimulated	NULL
cells	NULL
and	NULL
is	NULL
specifically	NULL
competed	NULL
by	NULL
unlabeled	NULL
excess	NULL
oligo	NULL
,	NULL
but	NULL
not	NULL
by	NULL
mutant	NULL
competitor	NULL
.	NULL

LPS	NULL
treatment	NULL
results	NULL
in	NULL
markedly	NULL
increased	NULL
specific	NULL
binding	NULL
activity	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Gel-shift	NULL
assay	NULL
using	NULL
5	NULL
g	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
control-	NULL
or	NULL
zymosan-treated	NULL
J774	NULL
cells	NULL
.	NULL

Zymosan	NULL
treatment	NULL
results	NULL
in	NULL
increased	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
.	NULL

(	NULL
£	NULL
)	NULL
Gel-shift	NULL
assay	NULL
using	NULL
a	NULL
consensus	NULL
NF-kB	NULL
sequence	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA	NULL
and	NULL
LPS-treated	NULL
U937	NULL
cells	NULL
.	NULL

Binding	NULL
activity	NULL
is	NULL
increased	NULL
by	NULL
PMA	NULL
and	NULL
LPS-treatment	NULL
of	NULL
U937	NULL
cells	NULL
.	NULL

Note	NULL
that	NULL
specific	NULL
binding	NULL
(	NULL
arrows	NULL
)	NULL
is	NULL
competed	NULL
by	NULL
excess	NULL
unlabeled	NULL
consensus	NULL
competitor	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
collagenase	NULL
NF-kB-like	NULL
sequence	NULL
.	NULL

1896	NULL
_	NULL
R.A.	NULL
Pierce	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
G.A	NULL
.	NULL

Doyle	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
duction	NULL
of	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
was	NULL
also	NULL
evident	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
D	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
NF-	NULL
«	NULL
B-like	NULL
site	NULL
in	NULL
the	NULL
collagenase	NULL
promoter	NULL
is	NULL
functional	NULL
in	NULL
binding	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
this	NULL
sequence	NULL
was	NULL
used	NULL
to	NULL
compete	NULL
binding	NULL
to	NULL
an	NULL
NF-kB	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
E	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
control	NULL
U937	NULL
cells	NULL
exhibited	NULL
some	NULL
basal	NULL
level	NULL
of	NULL
binding	NULL
activity	NULL
for	NULL
the	NULL
consensus	NULL
NFkB	NULL
sequence	NULL
.	NULL

This	NULL
was	NULL
readily	NULL
competed	NULL
by	NULL
25-fold	NULL
excess	NULL
unlabeled	NULL
consensus	NULL
competitor	NULL
,	NULL
but	NULL
not	NULL
by	NULL
a	NULL
25-fold	NULL
excess	NULL
of	NULL
double-stranded	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
collagenase	NULL
pro-moter	NULL
.	NULL

Specific	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
NF-kB	NULL
oligonucleotide	NULL
was	NULL
increased	NULL
in	NULL
extracts	NULL
from	NULL
PMA-differentiated	NULL
cells	NULL
and	NULL
markedly	NULL
induced	NULL
by	NULL
LPS	NULL
treatment	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
binding	NULL
activity	NULL
exhibited	NULL
in	NULL
extracts	NULL
from	NULL
control	NULL
cells	NULL
,	NULL
this	NULL
activity	NULL
was	NULL
not	NULL
competed	NULL
by	NULL
excess	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
collagenase	NULL
NF-xB-like	NULL
site	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
while	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
induced	NULL
by	NULL
LPS	NULL
treatment	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
kB-like	NULL
site	NULL
identified	NULL
in	NULL
the	NULL
collagenase	NULL
promoter	NULL
does	NULL
not	NULL
specifically	NULL
bind	NULL
the	NULL
NF-kB	NULL
complexes	NULL
.	NULL

C-Jun	NULL
,	NULL
Jun	NULL
B	NULL
,	NULL
Jun	NULL
D	NULL
,	NULL
and	NULL
c-Fos	NULL
are	NULL
present	NULL
in	NULL
LPS-induced	NULL
AP-1	NULL
complexes	NULL
.	NULL

To	NULL
define	NULL
the	NULL
specific	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
shifted	NULL
complexes	NULL
,	NULL
antibodies	NULL
to	NULL
specific	NULL
components	NULL
of	NULL
AP-1	NULL
complexes	NULL
were	NULL
used	NULL
in	NULL
supershift	NULL
assays	NULL
involving	NULL
LPS	NULL
stimulation	NULL
of	NULL
human	NULL
U937	NULL
cells	NULL
.	NULL

Supershifted	NULL
bands	NULL
were	NULL
detected	NULL
when	NULL
binding	NULL
reactions	NULL
included	NULL
antibodies	NULL
to	NULL
c-Jun	NULL
,	NULL
Jun	NULL
B	NULL
,	NULL
and	NULL
Jun	NULL
D	NULL
,	NULL
indicating	NULL
these	NULL
components	NULL
are	NULL
present	NULL
in	NULL
the	NULL
AP-1	NULL
complexes	NULL
induced	NULL
by	NULL
LPS	NULL
stimulation	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
an	NULL
anti-Fos	NULL
antibody	NULL
which	NULL
recognizes	NULL
all	NULL
members	NULL
of	NULL
the	NULL
fos	NULL
gene	NULL
family	NULL
and	NULL
a	NULL
specific	NULL
antibody	NULL
to	NULL
c-Fos	NULL
were	NULL
used	NULL
in	NULL
supershift	NULL
assays	NULL
,	NULL
resulting	NULL
in	NULL
altered	NULL
mobility	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
and	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
c-Fos	NULL
.	NULL

In	NULL
supershift	NULL
assays	NULL
employing	NULL
this	NULL
same	NULL
panel	NULL
of	NULL
antibodies	NULL
,	NULL
but	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
LPS	NULL
or	NULL
zymosan-treated	NULL
J774	NULL
cells	NULL
,	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
results	NULL
was	NULL
obtained	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AP-1	NULL
complexes	NULL
induced	NULL
by	NULL
LPS	NULL
in	NULL
mono	NULL
Antibody	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|panJun	NULL
]	NULL
eJun	NULL
|	NULL
JunB	NULL
|	NULL
JunD	NULL
|panfos|	NULL
c-Fos	NULL
Camper-km	NULL
-	NULL
-|	NULL
+	NULL
_	NULL
[	NULL
I+	NULL
-	NULL
]	NULL
+	NULL
_|+	NULL
_|+	NULL
_l+	NULL
-|+	NULL
extract	NULL
_|	NULL
-	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
[	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
+|+	NULL
-	NULL
#	NULL
am	NULL
webs	NULL
1	NULL
``	NULL
A	NULL
>	NULL
p	NULL
WoW	NULL
ow	NULL
=	NULL
w	NULL
|	NULL
+	NULL
%	NULL
I	NULL
“	NULL
Uu	NULL
:	NULL
uguul'lui	NULL
Figure	NULL
7	NULL
.	NULL

Supershift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA	NULL
and	NULL
LPS-treated	NULL
U937	NULL
cells	NULL
.	NULL

Gel-shift	NULL
assay	NULL
using	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
and	NULL
5	NULL
g	NULL
of	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
for	NULL
24	NULL
h	NULL
with	NULL
PMA	NULL
at	NULL
50	NULL
ng/ml	NULL
plus	NULL
LPS	NULL
at	NULL
10	NULL
pg/ml	NULL
.	NULL

Anti-pan-Jun	NULL
,	NULL
c-Jun	NULL
,	NULL
Jun	NULL
B	NULL
,	NULL
Jun	NULL
D	NULL
,	NULL
pan-Fos	NULL
,	NULL
and	NULL
c-Fos	NULL
antibodies	NULL
added	NULL
to	NULL
the	NULL
incubation	NULL
resulted	NULL
in	NULL
a	NULL
further	NULL
decrease	NULL
in	NULL
mobility	NULL
of	NULL
the	NULL
PMA	NULL
and	NULL
LPS-induced	NULL
AP-1	NULL
complexes	NULL
(	NULL
arrow	NULL
,	NULL
shifted	NULL
band	NULL
;	NULL
arrowheads	NULL
,	NULL
supershifted	NULL
band	NULL
)	NULL
.	NULL

cytic	NULL
cells	NULL
contain	NULL
specific	NULL
members	NULL
of	NULL
both	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
manuscript	NULL
,	NULL
we	NULL
present	NULL
the	NULL
novel	NULL
finding	NULL
that	NULL
a	NULL
72-bp	NULL
sequence	NULL
of	NULL
the	NULL
interstitial	NULL
collagenase	NULL
promoter	NULL
,	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
maximal	NULL
fold	NULL
induction	NULL
of	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
widely	NULL
recognized	NULL
that	NULL
AP-1	NULL
plays	NULL
a	NULL
vital	NULL
role	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
matrix	NULL
metalloproteinases	NULL
,	NULL
including	NULL
interstitial	NULL
collagenase	NULL
.	NULL

There	NULL
is	NULL
,	NULL
however	NULL
,	NULL
strong	NULL
evidence	NULL
that	NULL
sequences	NULL
upstream	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
are	NULL
necessary	NULL
for	NULL
maximal	NULL
fold	NULL
induction	NULL
of	NULL
collagenase	NULL
transcription	NULL
in	NULL
resident	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
1990	NULL
,	NULL
Gutman	NULL
and	NULL
Wasylyk	NULL
(	NULL
15	NULL
)	NULL
reported	NULL
that	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
LMTK~	NULL
)	NULL
,	NULL
the	NULL
human	NULL
collagenase	NULL
promoter	NULL
uses	NULL
a	NULL
phorbol-	NULL
and	NULL
oncogene-responsive	NULL
unit	NULL
that	NULL
encompasses	NULL
the	NULL
PEA-3-	NULL
and	NULL
AP-1-binding	NULL
sites	NULL
.	NULL

They	NULL
named	NULL
this	NULL
unit	NULL
TORU	NULL
(	NULL
TPA	NULL
and	NULL
oncogene-responsive	NULL
unit	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
PEA-3	NULL
site	NULL
resulted	NULL
in	NULL
markedly	NULL
lower	NULL
fold	NULL
induction	NULL
of	NULL
transcription	NULL
upon	NULL
phorbol	NULL
stimulation	NULL
or	NULL
cotransfection	NULL
with	NULL
oncogene	NULL
expression	NULL
vectors	NULL
.	NULL

In	NULL
1991	NULL
,	NULL
two	NULL
reports	NULL
from	NULL
Brinckerhoff	NULL
and	NULL
co-workers	NULL
(	NULL
10	NULL
,	NULL
14	NULL
)	NULL
indicated	NULL
that	NULL
upstream	NULL
elements	NULL
,	NULL
cooperating	NULL
with	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
were	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
transcription	NULL
in	NULL
fibroblasts	NULL
.	NULL

They	NULL
reported	NULL
that	NULL
a	NULL
PEA-3-like	NULL
element	NULL
and	NULL
also	NULL
a	NULL
TTCA	NULL
sequence	NULL
were	NULL
necessary	NULL
for	NULL
phorbol	NULL
inducibility	NULL
of	NULL
collagenase	NULL
transcription	NULL
in	NULL
fibroblasts	NULL
.	NULL

The	NULL
minimal	NULL
promoter	NULL
fragment	NULL
which	NULL
was	NULL
phorbol	NULL
responsive	NULL
was	NULL
127	NULL
bp	NULL
in	NULL
length	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
they	NULL
found	NULL
that	NULL
both	NULL
IL-1	NULL
and	NULL
phorbol	NULL
induction	NULL
of	NULL
the	NULL
stromelysin	NULL
promoter	NULL
requires	NULL
an	NULL
upstream	NULL
element	NULL
that	NULL
cooperates	NULL
with	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
fold	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
in	NULL
the	NULL
shortest	NULL
AP-1-containing	NULL
construct	NULL
was	NULL
two-	NULL
to	NULL
threefold	NULL
with	NULL
IL-1	NULL
or	NULL
phorbol	NULL
treatment	NULL
in	NULL
human	NULL
skin	NULL
fibroblasts	NULL
,	NULL
but	NULL
five-	NULL
to	NULL
sixfold	NULL
in	NULL
constructs	NULL
containing	NULL
upstream	NULL
sequences	NULL
,	NULL
indicating	NULL
that	NULL
cooperation	NULL
between	NULL
the	NULL
AP-1	NULL
site	NULL
and	NULL
upstream	NULL
elements	NULL
is	NULL
required	NULL
for	NULL
maximal	NULL
fold	NULL
induction	NULL
of	NULL
stromelysin	NULL
in	NULL
fibroblasts	NULL
.	NULL

Also	NULL
in	NULL
1991	NULL
,	NULL
Buttice	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
reported	NULL
that	NULL
the	NULL
AP-1	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
basal	NULL
and	NULL
maximal	NULL
activity	NULL
of	NULL
the	NULL
stromelysin	NULL
promoter	NULL
,	NULL
but	NULL
not	NULL
for	NULL
phorbol	NULL
induction	NULL
,	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
cells	NULL
.	NULL

In	NULL
1993	NULL
,	NULL
Buttice	NULL
and	NULL
Kurkinen	NULL
(	NULL
38	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
PEA-3	NULL
site	NULL
,	NULL
5	NULL
``	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
phorbol	NULL
induction	NULL
of	NULL
the	NULL
stromelysin	NULL
gene	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
studies	NULL
emphasize	NULL
that	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
fibroblasts	NULL
,	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
elements	NULL
upstream	NULL
to	NULL
AP-1	NULL
are	NULL
critical	NULL
for	NULL
maximal	NULL
fold	NULL
induction	NULL
of	NULL
metalloproteinase	NULL
transcription	NULL
.	NULL

Indeed	NULL
,	NULL
fold	NULL
induction	NULL
was	NULL
increased	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
two	NULL
to	NULL
five	NULL
by	NULL
inclusion	NULL
of	NULL
upstream	NULL
sequences	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

The	NULL
previous	NULL
reports	NULL
contrast	NULL
strongly	NULL
with	NULL
our	NULL
findings	NULL
regarding	NULL
collagenase	NULL
induction	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

In	NULL
PMA	NULL
ferentiated	NULL
U937	NULL
cells	NULL
,	NULL
the	NULL
fold	NULL
induction	NULL
of	NULL
the	NULL
-72	NULL
construct	NULL
on	NULL
LPS	NULL
treatment	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
fold	NULL
induction	NULL
observed	NULL
with	NULL
constructs	NULL
containing	NULL
additional	NULL
5	NULL
``	NULL
flanking	NULL
sequences	NULL
up	NULL
to	NULL
2278	NULL
bp	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
murine	NULL
J774	NULL
cells	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
LPS	NULL
induction	NULL
of	NULL
a	NULL
construct	NULL
containing	NULL
only	NULL
72	NULL
bp	NULL
of	NULL
5	NULL
flanking	NULL
sequence	NULL
was	NULL
equal	NULL
to	NULL
constructs	NULL
containing	NULL
179	NULL
,	NULL
511	NULL
,	NULL
or	NULL
2278	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

While	NULL
absolute	NULL
promoter	NULL
activity	NULL
is	NULL
maximal	NULL
with	NULL
larger	NULL
constructs	NULL
in	NULL
our	NULL
studies	NULL
,	NULL
this	NULL
finding	NULL
does	NULL
not	NULL
indicate	NULL
that	NULL
upstream	NULL
elements	NULL
are	NULL
LPS-or	NULL
zymosan-responsive	NULL
,	NULL
but	NULL
rather	NULL
that	NULL
upstream	NULL
elements	NULL
are	NULL
Cell	NULL
Type-specific	NULL
Collagenase	NULL
Transcription	NULL
1897	NULL
necessary	NULL
for	NULL
full	NULL
basal	NULL
and	NULL
induced	NULL
transcriptional	NULL
activity	NULL
.	NULL

This	NULL
is	NULL
fundamentally	NULL
different	NULL
from	NULL
the	NULL
previous	NULL
studies	NULL
in	NULL
resident	NULL
cells	NULL
outlined	NULL
above	NULL
,	NULL
where	NULL
upstream	NULL
elements	NULL
were	NULL
clearly	NULL
responsive	NULL
to	NULL
either	NULL
phorbol	NULL
ester	NULL
or	NULL
IL-1	NULL
.	NULL

In	NULL
those	NULL
studies	NULL
,	NULL
additional	NULL
sequences	NULL
conferred	NULL
greater	NULL
fold	NULL
induction	NULL
of	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
delineate	NULL
collagenase	NULL
promoter	NULL
elements	NULL
responsive	NULL
to	NULL
macrophage-specific	NULL
mediators	NULL
and	NULL
to	NULL
suggest	NULL
that	NULL
elements	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
from	NULL
-72	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
alone	NULL
can	NULL
be	NULL
sufficient	NULL
to	NULL
mediate	NULL
this	NULL
gene	NULL
's	NULL
induction	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

The	NULL
cell	NULL
model	NULL
systems	NULL
we	NULL
used	NULL
included	NULL
both	NULL
PMA	NULL
-differentiated	NULL
U937	NULL
human	NULL
monocytic	NULL
cells	NULL
and	NULL
macrophage-like	NULL
murine	NULL
J774	NULL
cells	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
offered	NULL
advantages	NULL
for	NULL
this	NULL
study	NULL
.	NULL

Notably	NULL
,	NULL
there	NULL
are	NULL
no	NULL
spontaneously	NULL
adherent	NULL
human	NULL
monocytic	NULL
cell	NULL
lines	NULL
capable	NULL
of	NULL
responding	NULL
directly	NULL
to	NULL
LPS	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
used	NULL
PMA-differentiated	NULL
human	NULL
U937	NULL
cells	NULL
,	NULL
which	NULL
responded	NULL
potently	NULL
to	NULL
LPS	NULL
stimulation	NULL
.	NULL

We	NULL
also	NULL
studied	NULL
murine	NULL
J774	NULL
cells	NULL
to	NULL
complement	NULL
and	NULL
validate	NULL
our	NULL
studies	NULL
in	NULL
the	NULL
human	NULL
U937	NULL
cells	NULL
,	NULL
because	NULL
these	NULL
cells	NULL
are	NULL
pheno-typically	NULL
very	NULL
similar	NULL
to	NULL
tissue	NULL
macrophages	NULL
.	NULL

They	NULL
are	NULL
spontaneously	NULL
adherent	NULL
and	NULL
respond	NULL
directly	NULL
to	NULL
LPS	NULL
.	NULL

In	NULL
murine	NULL
cells	NULL
and	NULL
tissues	NULL
,	NULL
however	NULL
,	NULL
MMP-13	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
only	NULL
collagenase	NULL
present	NULL
.	NULL

Indeed	NULL
,	NULL
expression	NULL
of	NULL
MMP-13	NULL
was	NULL
induced	NULL
by	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
cells	NULL
possess	NULL
all	NULL
the	NULL
machinery	NULL
necessary	NULL
to	NULL
upregulate	NULL
metalloproteinase	NULL
expression	NULL
,	NULL
precisely	NULL
as	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
do	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
results	NULL
between	NULL
the	NULL
phorbol-differentiated	NULL
U937	NULL
cells	NULL
and	NULL
J774	NULL
cells	NULL
strongly	NULL
suggests	NULL
that	NULL
the	NULL
responsive	NULL
elements	NULL
of	NULL
MMP	NULL
genes	NULL
and	NULL
the	NULL
nuclear	NULL
factors	NULL
conferring	NULL
transactivation	NULL
operate	NULL
across	NULL
mammalian	NULL
species	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
induction	NULL
of	NULL
nuclear	NULL
proteins	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
collagenase	NULL
AP-1	NULL
site	NULL
was	NULL
markedly	NULL
upregulated	NULL
by	NULL
LPS	NULL
treatment	NULL
of	NULL
PMA-differentiated	NULL
U937	NULL
cells	NULL
and	NULL
by	NULL
LPS	NULL
or	NULL
zymosan	NULL
treatment	NULL
of	NULL
J774	NULL
cells	NULL
.	NULL

Further	NULL
analysis	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
individual	NULL
components	NULL
of	NULL
the	NULL
AP-1	NULL
complexes	NULL
identified	NULL
c-Jun	NULL
,	NULL
Jun	NULL
B	NULL
,	NULL
Jun	NULL
D	NULL
,	NULL
and	NULL
c-Fos	NULL
in	NULL
protein	NULL
complexes	NULL
bound	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

Because	NULL
the	NULL
antibodies	NULL
used	NULL
may	NULL
differ	NULL
in	NULL
their	NULL
affinities	NULL
and	NULL
efficiency	NULL
of	NULL
binding	NULL
under	NULL
experimental	NULL
conditions	NULL
,	NULL
these	NULL
assays	NULL
do	NULL
not	NULL
ascertain	NULL
which	NULL
of	NULL
these	NULL
components	NULL
are	NULL
predominant	NULL
.	NULL

Angel	NULL
and	NULL
Karin	NULL
(	NULL
1992	NULL
)	NULL
showed	NULL
that	NULL
c-Jun	NULL
is	NULL
necessary	NULL
for	NULL
collagenase	NULL
activation	NULL
(	NULL
40	NULL
)	NULL
.	NULL

If	NULL
this	NULL
requirement	NULL
for	NULL
c-Jun	NULL
is	NULL
operative	NULL
in	NULL
transactivation	NULL
of	NULL
monocytic	NULL
cells	NULL
as	NULL
well	NULL
,	NULL
c-Jun/c-Fos	NULL
heterodimers	NULL
may	NULL
predominate	NULL
in	NULL
LPS-	NULL
or	NULL
zymosan-stimulated	NULL
macrophagelike	NULL
cells	NULL
.	NULL

LPS	NULL
binding	NULL
to	NULL
CD14	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
41	NULL
)	NULL
starts	NULL
a	NULL
cascade	NULL
of	NULL
signal	NULL
transduction	NULL
which	NULL
ultimately	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
transcription	NULL
factors	NULL
,	NULL
among	NULL
others	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
identified	NULL
an	NULL
NF-xB-like	NULL
sequence	NULL
in	NULL
the	NULL
collagenase	NULL
promoter	NULL
between	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
transcription	NULL
initiation	NULL
site	NULL
,	NULL
yet	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
failed	NULL
to	NULL
affect	NULL
LPS-mediated	NULL
transactivation	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
LPS-stimulated	NULL
cells	NULL
to	NULL
a	NULL
consensus	NULL
NF-kB	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
immunoglobulin	NULL
kappa	NULL
gene	NULL
enhancer	NULL
indicated	NULL
that	NULL
NF-kB	NULL
was	NULL
strongly	NULL
upregulated	NULL
by	NULL
LPS	NULL
treatment	NULL
;	NULL
however	NULL
,	NULL
this	NULL
binding	NULL
activity	NULL
was	NULL
not	NULL
efficiently	NULL
competed	NULL
by	NULL
excess	NULL
unlabeled	NULL
collagenase	NULL
NF-kB-like	NULL
sequences	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
deletion	NULL
or	NULL
mutagenesis	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
completely	NULL
abrogated	NULL
collagenase	NULL
transactivation	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
treatment	NULL
.	NULL

Therefore	NULL
,	NULL
collagenase	NULL
transactivation	NULL
by	NULL
LPS	NULL
in	NULL
dependent	NULL
upon	NULL
AP-1	NULL
,	NULL
but	NULL
exhibits	NULL
no	NULL
involvement	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B-like	NULL
1898	NULL
_	NULL
R.A.	NULL
Pierce	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
G.A	NULL
.	NULL

Doyle	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
site	NULL
.	NULL

While	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
participation	NULL
of	NULL
other	NULL
sequences	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
(	NULL
in	NULL
addition	NULL
to	NULL
-2278	NULL
to	NULL
+36	NULL
)	NULL
in	NULL
the	NULL
LPS-mediated	NULL
transcriptional	NULL
induction	NULL
in	NULL
macrophages	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
sequences	NULL
between	NULL
-72	NULL
and	NULL
-55	NULL
,	NULL
including	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
are	NULL
critical	NULL
for	NULL
this	NULL
response	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
upstream	NULL
promoter	NULL
elements	NULL
such	NULL
as	NULL
PEA-3	NULL
and	NULL
TTCA	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
resident	NULL
cell	NULL
induction	NULL
of	NULL
collagenase	NULL
expression	NULL
,	NULL
contribute	NULL
little	NULL
or	NULL
nothing	NULL
to	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
elements	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
from	NULL
-72	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
alone	NULL
can	NULL
be	NULL
sufficient	NULL
to	NULL
mediate	NULL
this	NULL
gene	NULL
's	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
macrophage-specific	NULL
mediators	NULL
such	NULL
as	NULL
LPS	NULL
and	NULL
zymosan	NULL
.	NULL

These	NULL
results	NULL
emphasize	NULL
the	NULL
cell	NULL
type-specific	NULL
differences	NULL
which	NULL
exist	NULL
in	NULL
metalloproteinase	NULL
expression	NULL
and	NULL
may	NULL
have	NULL
important	NULL
implications	NULL
for	NULL
understanding	NULL
pathogenetic	NULL
mechanisms	NULL
in	NULL
diseases	NULL
such	NULL
as	NULL
atherosclerosis	NULL
and	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
William	NULL
Parks	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
Dr.	NULL
Stephen	NULL
Frisch	NULL
for	NULL
providing	NULL
pCLCAT	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
HL-29594	NULL
and	NULL
HL-54049	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
a	NULL
Career	NULL
Development	NULL
Award	NULL
from	NULL
the	NULL
Dermatology	NULL
Foundation	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Welgus	NULL
,	NULL
H.G	NULL
.	NULL

,	NULL
J.J.	NULL
Jeffrey	NULL
,	NULL
and	NULL
A.Z	NULL
.	NULL

Eisen	NULL
.	NULL

1981	NULL
.	NULL

The	NULL
collagen	NULL
substrate	NULL
specificity	NULL
of	NULL
human	NULL
skin	NULL
fibroblast	NULL
collagenase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256:9511-9515	NULL
.	NULL

2	NULL
.	NULL

Goldberg	NULL
,	NULL
G.1	NULL
.	NULL

,	NULL
S.M	NULL
.	NULL

Wilhelm	NULL
,	NULL
A.	NULL
Kronberger	NULL
,	NULL
E.A	NULL
.	NULL

Bauer	NULL
,	NULL
G.A	NULL
.	NULL

Grant	NULL
,	NULL
and	NULL
A.Z	NULL
.	NULL

Eisen	NULL
.	NULL

1986	NULL
.	NULL

Human	NULL
fibroblast	NULL
collagenase	NULL
.	NULL

Complete	NULL
primary	NULL
structure	NULL
and	NULL
homology	NULL
to	NULL
an	NULL
oncogene	NULL
transformation-induced	NULL
rat	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261:6600-6605	NULL
.	NULL

3	NULL
.	NULL

Hasty	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
T.F	NULL
.	NULL

Pourmotabbed	NULL
,	NULL
G.I	NULL
.	NULL

Goldberg	NULL
,	NULL
J.P.	NULL
Thompson	NULL
,	NULL
D.G	NULL
.	NULL

Spinella	NULL
,	NULL
R.M	NULL
.	NULL

Steens	NULL
,	NULL
and	NULL
C.L	NULL
.	NULL

Mainardi	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
neutrophil	NULL
collagenase	NULL
.	NULL

A	NULL
distinct	NULL
gene	NULL
product	NULL
with	NULL
homology	NULL
to	NULL
other	NULL
matrix	NULL
metalloproteinases	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:11421-11424	NULL
.	NULL

4	NULL
.	NULL

Quinn	NULL
,	NULL
C.O	NULL
.	NULL

,	NULL
D.K	NULL
.	NULL

Scott	NULL
,	NULL
C.E	NULL
.	NULL

Brinckerhoff	NULL
,	NULL
L.M	NULL
.	NULL

Matrisian	NULL
,	NULL
J.J.	NULL
Jeffrey	NULL
,	NULL
and	NULL
N.C.	NULL
Partridge	NULL
.	NULL

1990	NULL
.	NULL

Rat	NULL
collagenase	NULL
:	NULL
cloning	NULL
,	NULL
amino	NULL
acid	NULL
sequence	NULL
com-parison	NULL
,	NULL
and	NULL
parathyroid	NULL
hormone	NULL
regulation	NULL
in	NULL
osteoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:22342-22347	NULL
.	NULL

5	NULL
.	NULL

Freije	NULL
,	NULL
J.M.P	NULL
.	NULL

,	NULL
I.	NULL
Diez-Itza	NULL
,	NULL
M.	NULL
Balbin	NULL
,	NULL
L.M	NULL
.	NULL

Sanchez	NULL
,	NULL
R.	NULL
Blasco	NULL
,	NULL
J.	NULL
To-livia	NULL
,	NULL
and	NULL
C.	NULL
Lopez-Otin	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
collage-nase-3	NULL
,	NULL
a	NULL
novel	NULL
human	NULL
matrix	NULL
metalloproteinase	NULL
produced	NULL
by	NULL
breast	NULL
carcino-mas	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:16766-16773	NULL
.	NULL

6	NULL
.	NULL

Murphy	NULL
,	NULL
G.	NULL
,	NULL
M.L	NULL
.	NULL

Crockett	NULL
,	NULL
R.V	NULL
.	NULL

Ward	NULL
,	NULL
and	NULL
A.J.P	NULL
.	NULL

Docherty	NULL
.	NULL

1991	NULL
.	NULL

Matrix	NULL
metalloproteinase	NULL
degradation	NULL
of	NULL
elastin	NULL
,	NULL
type	NULL
IV	NULL
collagen	NULL
and	NULL
proteogly-can	NULL
.	NULL

A	NULL
quantitative	NULL
comparison	NULL
of	NULL
the	NULL
activities	NULL
of	NULL
95	NULL
kDa	NULL
and	NULL
75	NULL
kDa	NULL
gelati-nases	NULL
,	NULL
stromelysins-1	NULL
and	NULL
-2	NULL
and	NULL
punctuated	NULL
metalloproteinase	NULL
(	NULL
PUMP	NULL
)	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

277:277-279	NULL
.	NULL

7	NULL
.	NULL

McDonnell	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
L.D	NULL
.	NULL

Kerr	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Matrisian	NULL
.	NULL

1990	NULL
.	NULL

Epidermal	NULL
growth	NULL
factor	NULL
stimulation	NULL
of	NULL
stromelysin	NULL
mRNA	NULL
in	NULL
rat	NULL
fibroblasts	NULL
requires	NULL
induction	NULL
of	NULL
protooncogenes	NULL
c-fos	NULL
and	NULL
c-jun	NULL
and	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:4284-4293	NULL
.	NULL

8	NULL
.	NULL

Edwards	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
G.	NULL
Murphy	NULL
,	NULL
J.J.	NULL
Reynolds	NULL
,	NULL
S.E	NULL
.	NULL

Whitham	NULL
,	NULL
A.J.P	NULL
.	NULL

Do-cherty	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
J.K.	NULL
Heath	NULL
.	NULL

1987	NULL
.	NULL

Transforming	NULL
growth	NULL
factor	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
collagenase	NULL
and	NULL
metalloproteinase	NULL
inhibitor	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

6:1899-1904	NULL
.	NULL

9	NULL
.	NULL

Brenner	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
M.	NULL
O'Hara	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
M.	NULL
Chojkier	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Prolonged	NULL
activation	NULL
of	NULL
jun	NULL
and	NULL
collagenase	NULL
genes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

337:661-663	NULL
.	NULL

10	NULL
.	NULL

Sirum-Conolly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
C.E	NULL
.	NULL

Brinckerhoff	NULL
.	NULL

1991	NULL
.	NULL

Interleukin-1	NULL
or	NULL
phorbol	NULL
induction	NULL
of	NULL
the	NULL
stromelysin	NULL
promoter	NULL
requires	NULL
an	NULL
element	NULL
that	NULL
cooperates	NULL
with	NULL
AP-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:335-341	NULL
.	NULL

11	NULL
.	NULL

Cury	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
E.J	NULL
.	NULL

Campbell	NULL
,	NULL
C.J	NULL
.	NULL

Lazarus	NULL
,	NULL
R.J.	NULL
Albin	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
.	NULL

1988	NULL
.	NULL

Selective	NULL
upregulation	NULL
of	NULL
human	NULL
alveolar	NULL
macrophage	NULL
collagenase	NULL
production	NULL
by	NULL
lipopolysaccharide	NULL
and	NULL
comparison	NULL
to	NULL
collagenase	NULL
production	NULL
in	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

14:4306-4312	NULL
.	NULL

12	NULL
.	NULL

Shapiro	NULL
,	NULL
S.D	NULL
.	NULL

,	NULL
D.K	NULL
.	NULL

Kobayashi	NULL
,	NULL
and	NULL
H.G	NULL
.	NULL

Welgus	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
TIMP-2	NULL
in	NULL
human	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Regulation	NULL
of	NULL
biosynthesis	NULL
is	NULL
opposite	NULL
to	NULL
that	NULL
of	NULL
metalloproteinases	NULL
and	NULL
TIMP-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:13890-13894	NULL
.	NULL

13	NULL
.	NULL

Saarialho-Kere	NULL
,	NULL
U.K.	NULL
,	NULL
H.G	NULL
.	NULL

Welgus	NULL
,	NULL
and	NULL
W.C	NULL
.	NULL

Parks	NULL
.	NULL

1993	NULL
.	NULL

Divergent	NULL
mechanisms	NULL
regulate	NULL
interstitial	NULL
collagenase	NULL
and	NULL
92	NULL
dKa	NULL
gelatinase	NULL
expression	NULL
in	NULL
human	NULL
monocytic-like	NULL
cells	NULL
exposed	NULL
to	NULL
bacterial	NULL
endotoxin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:17354-17361	NULL
.	NULL

14	NULL
.	NULL

Auble	NULL
,	NULL
D.T	NULL
.	NULL

,	NULL
and	NULL
C.E	NULL
.	NULL

Brinkerhoff	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
AP-1	NULL
sequence	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
phorbol	NULL
induction	NULL
of	NULL
collagenase	NULL
in	NULL
fibroblasts	NULL
.	NULL

Bio-chemistry	NULL
.	NULL

30:4629-4635	NULL
.	NULL

15	NULL
.	NULL

Gutman	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
B.	NULL
Wasylyk	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
collagenase	NULL
gene	NULL
promoter	NULL
contains	NULL
a	NULL
TPA	NULL
and	NULL
oncogene-responsive	NULL
unit	NULL
encompassing	NULL
the	NULL
PEA3	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

92241-2246	NULL
.	NULL

16	NULL
.	NULL

Firestein	NULL
,	NULL
G.S	NULL
.	NULL

,	NULL
M.M	NULL
.	NULL

Paine	NULL
,	NULL
and	NULL
B.H	NULL
.	NULL

Littman	NULL
.	NULL

1991	NULL
.	NULL

Gene	NULL
expression	NULL
(	NULL
collagenase	NULL
,	NULL
tissue	NULL
inhibitor	NULL
of	NULL
metalloproteinases	NULL
,	NULL
complement	NULL
,	NULL
and	NULL
HLA-DR	NULL
)	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
osteoarthritis	NULL
synovium	NULL
.	NULL

Quantitative	NULL
analysis	NULL
and	NULL
effect	NULL
of	NULL
intraarticular	NULL
corticosteroids	NULL
.	NULL

Arthritis	NULL
&	NULL
Rheum	NULL
.	NULL

34:1094-1105	NULL
.	NULL

17	NULL
.	NULL

McCachren	NULL
,	NULL
$	NULL
.S	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
metalloproteinases	NULL
and	NULL
metalloproteinase	NULL
inhibitor	NULL
in	NULL
human	NULL
arthritic	NULL
synovium	NULL
.	NULL

Arthritis	NULL
&	NULL
Rheum	NULL
.	NULL

34:1085-1093	NULL
.	NULL

18	NULL
.	NULL

Galis	NULL
,	NULL
Z.S	NULL
.	NULL

,	NULL
M.W	NULL
.	NULL

Suckhova	NULL
,	NULL
M.W	NULL
.	NULL

Lark	NULL
,	NULL
and	NULL
P.	NULL
Libby	NULL
.	NULL

1994	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
matrix	NULL
metalloproteinases	NULL
and	NULL
matrix	NULL
degrading	NULL
activity	NULL
in	NULL
vulnerable	NULL
regions	NULL
of	NULL
human	NULL
atherosclerotic	NULL
plaques	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:2493-2503	NULL
.	NULL

19	NULL
.	NULL

Nikkari	NULL
,	NULL
S.T	NULL
.	NULL

,	NULL
K.D	NULL
.	NULL

O'Brien	NULL
,	NULL
M.	NULL
Ferguson	NULL
,	NULL
T.	NULL
Hatsukami	NULL
,	NULL
H.G	NULL
.	NULL

Welgus	NULL
,	NULL
C.E	NULL
.	NULL

Alpers	NULL
,	NULL
and	NULL
A.W	NULL
.	NULL

Clowes	NULL
.	NULL

1995	NULL
.	NULL

Interstitial	NULL
collagenase	NULL
(	NULL
MMP-1	NULL
)	NULL
expression	NULL
in	NULL
human	NULL
carotid	NULL
atherosclerosis	NULL
.	NULL

Circulation	NULL
.	NULL

92:1393-1398	NULL
.	NULL

20	NULL
.	NULL

Hazuda	NULL
,	NULL
D.J	NULL
.	NULL

,	NULL
J.C.	NULL
Lee	NULL
,	NULL
and	NULL
P.R	NULL
.	NULL

Young	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
IL-1	NULL
secretion	NULL
from	NULL
activated	NULL
monocytes	NULL
.	NULL

Differences	NULL
between	NULL
interleukin	NULL
1	NULL
«	NULL
and	NULL
interleukin	NULL
1B	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:8473	NULL
.	NULL

21	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
N.	NULL
Krochin	NULL
,	NULL
I.	NULL
W.	NULL
Milsark	NULL
,	NULL
C.	NULL
Leudke	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1986	NULL
.	NULL

Control	NULL
of	NULL
cachectin	NULL
(	NULL
tumor	NULL
necrosis	NULL
factor	NULL
)	NULL
synthesis	NULL
:	NULL
mechanisms	NULL
of	NULL
endo-toxin	NULL
resistance	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

249:977	NULL
.	NULL

22	NULL
.	NULL

Bauer	NULL
,	NULL
J.	NULL
,	NULL
U.	NULL
Ganter	NULL
,	NULL
T.	NULL
Geiger	NULL
,	NULL
U.	NULL
Jacobshagen	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Matsuda	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
T.	NULL
Andus	NULL
,	NULL
G.	NULL
Acs	NULL
,	NULL
W.	NULL
Gerok	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
.	NULL

Regulation	NULL
of	NULL
interleu-kin-6	NULL
expression	NULL
in	NULL
cultured	NULL
human	NULL
blood	NULL
monocytes	NULL
and	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

Blood	NULL
.	NULL

72:1134	NULL
.	NULL

23	NULL
.	NULL

Collart	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
P.	NULL
Bauerle	NULL
,	NULL
and	NULL
P.	NULL
Vassali	NULL
.	NULL

1990	NULL
.	NULL

Regulation	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
transcription	NULL
in	NULL
macrophages	NULL
:	NULL
involvement	NULL
of	NULL
four	NULL
xB-like	NULL
motifs	NULL
and	NULL
of	NULL
constitutive	NULL
and	NULL
inducible	NULL
forms	NULL
of	NULL
NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
:	NULL
1498-1506	NULL
.	NULL

24	NULL
.	NULL

Goldfield	NULL
,	NULL
A.E	NULL
.	NULL

,	NULL
C.	NULL
Doyle	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87:9769-9773	NULL
.	NULL

25	NULL
.	NULL

Drouet	NULL
,	NULL
C.	NULL
,	NULL
A.N	NULL
.	NULL

Shakhov	NULL
,	NULL
and	NULL
C.V.	NULL
Jongeneel	NULL
.	NULL

1991	NULL
.	NULL

Enhancers	NULL
and	NULL
transcription	NULL
factors	NULL
controlling	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
promoter	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:1694-1700	NULL
.	NULL

26	NULL
.	NULL

Ways	NULL
,	NULL
J.P.	NULL
,	NULL
and	NULL
J.G	NULL
.	NULL

Gray	NULL
.	NULL

1994	NULL
.	NULL

NF-kappa	NULL
B	NULL
regulates	NULL
IL-1	NULL
beta	NULL
transcription	NULL
through	NULL
a	NULL
consensus	NULL
NF-kappa	NULL
B	NULL
binding	NULL
site	NULL
and	NULL
a	NULL
nonconsensus	NULL
CRE-like	NULL
site	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:712-723	NULL
.	NULL

27	NULL
.	NULL

Mackman	NULL
,	NULL
N.	NULL
,	NULL
K.	NULL
Brand	NULL
,	NULL
and	NULL
T.S	NULL
.	NULL

Edgington	NULL
.	NULL

1991	NULL
.	NULL

Lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
tissue	NULL
factor	NULL
gene	NULL
in	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
requires	NULL
both	NULL
activator	NULL
protein	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
kB	NULL
binding	NULL
sites	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:1517-1526	NULL
.	NULL

28	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
.	NULL

58:227-229	NULL
.	NULL

29	NULL
.	NULL

Pierce	NULL
,	NULL
R.A.	NULL
,	NULL
W.I	NULL
.	NULL

Mariencheck	NULL
,	NULL
S.	NULL
Sandefur	NULL
,	NULL
E.C	NULL
.	NULL

Crouch	NULL
,	NULL
and	NULL
W.C	NULL
.	NULL

Parks	NULL
.	NULL

1995	NULL
.	NULL

Glucocorticoids	NULL
upregulate	NULL
tropoelastin	NULL
expression	NULL
during	NULL
late	NULL
stages	NULL
of	NULL
fetal	NULL
lung	NULL
development	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

268	NULL
:	NULL
L491-L500	NULL
.	NULL

30	NULL
.	NULL

An	NULL
,	NULL
G.	NULL
,	NULL
K.	NULL
Hidaka	NULL
,	NULL
and	NULL
L.	NULL
Siminovitch	NULL
.	NULL

1982	NULL
.	NULL

Expression	NULL
of	NULL
bacterial	NULL
B-galactosidase	NULL
in	NULL
animal	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1628-1632	NULL
.	NULL

31	NULL
.	NULL

Gorman	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
L.F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.H	NULL
.	NULL

Howell	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

32	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162:156-159	NULL
.	NULL

33	NULL
.	NULL

Fort	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Piechacezyk	NULL
,	NULL
S.	NULL
El	NULL
Sabrouty	NULL
,	NULL
C.	NULL
Danz	NULL
,	NULL
I.	NULL
Jeatner	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

Blanchard	NULL
.	NULL

1985	NULL
.	NULL

Various	NULL
rat	NULL
adult	NULL
tissues	NULL
express	NULL
only	NULL
one	NULL
major	NULL
mRNA	NULL
species	NULL
from	NULL
the	NULL
glyceraldehyde-3-phosphate	NULL
multigene	NULL
family	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13:1431-1442	NULL
.	NULL

34	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:5490	NULL
.	NULL

35	NULL
.	NULL

Ho	NULL
,	NULL
S.N	NULL
.	NULL

,	NULL
HD	NULL
.	NULL

Hunt	NULL
,	NULL
R.M	NULL
.	NULL

Horton	NULL
,	NULL
J.K.	NULL
Pullen	NULL
,	NULL
and	NULL
L.R	NULL
.	NULL

Pease	NULL
.	NULL

1989	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
by	NULL
overlap	NULL
extension	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
re-action	NULL
.	NULL

Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

.	NULL

77:51-59	NULL
.	NULL

36	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Martin	NULL
,	NULL
B.	NULL
Shastry	NULL
,	NULL
and	NULL
R.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Eucaryotic	NULL
gene	NULL
transcription	NULL
with	NULL
purified	NULL
components	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

101:582-598	NULL
.	NULL

37	NULL
.	NULL

Ausubel	NULL
,	NULL
FM	NULL
.	NULL

,	NULL
R.	NULL
Brent	NULL
,	NULL
RE	NULL
.	NULL

Kingston	NULL
,	NULL
D.D	NULL
.	NULL

Moore	NULL
,	NULL
J.G	NULL
.	NULL

Seidman	NULL
,	NULL
J.A	NULL
.	NULL

Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
.	NULL

1987	NULL
.	NULL

Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
.	NULL

John	NULL
Wiley	NULL
and	NULL
Sons	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

12.1.1-12.1.10	NULL
.	NULL

38	NULL
.	NULL

Buttice	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
M.	NULL
Kurkinen	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
Polyoma	NULL
Enhancer	NULL
A-binding	NULL
Protein-3	NULL
site	NULL
and	NULL
Ets	NULL
protein	NULL
have	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
12-O-tetradecanoylphor-bol-13-acetate	NULL
response	NULL
of	NULL
the	NULL
human	NULL
stromelysin	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
7196-7204	NULL
.	NULL

39	NULL
.	NULL

Buttice	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Quinines	NULL
,	NULL
and	NULL
M.	NULL
Kurkinien	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
AP-1	NULL
site	NULL
is	NULL
required	NULL
for	NULL
basal	NULL
expression	NULL
but	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
TPA-response	NULL
of	NULL
the	NULL
human	NULL
stromelysis	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:3723-3731	NULL
.	NULL

40	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
MI	NULL
.	NULL

Karin	NULL
.	NULL

1992	NULL
.	NULL

Specific	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
protein	NULL
family	NULL
regulate	NULL
collagenase	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
various	NULL
extracellular	NULL
stimuli	NULL
.	NULL

In	NULL
Matrix	NULL
Metalloproteinases	NULL
and	NULL
Inhibitors	NULL
.	NULL

H.	NULL
Birkedahl-Hansen	NULL
,	NULL
Z.	NULL
Werb	NULL
,	NULL
H.G	NULL
.	NULL

Welgus	NULL
,	NULL
and	NULL
H.E	NULL
.	NULL

van	NULL
Wart	NULL
,	NULL
editors	NULL
.	NULL

Gustav	NULL
Fischer	NULL
,	NULL
Stuttgart	NULL
.	NULL

156-164	NULL
.	NULL

41	NULL
.	NULL

Wright	NULL
,	NULL
S.D	NULL
.	NULL

,	NULL
R.A.	NULL
Ramos	NULL
,	NULL
P.S	NULL
.	NULL

Tobias	NULL
,	NULL
R.J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
J.C.	NULL
Mathi-son	NULL
.	NULL

1990	NULL
.	NULL

CD14	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
complexes	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
LPS	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

249:1431-1433	NULL
.	NULL

Cell	NULL
Type-specific	NULL
Collagenase	NULL
Transcription	NULL
1899	NULL

